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Cryptococcus neoformans is a basidiomycetous fungal pathogen that claims 
625,000 lives annually worldwide. Particularly among the immunocompromised, it is the 
leading cause of fungal meningitis following pulmonary colonization and dissemination 
to the central nervous system via the blood-brain barrier. The success of C. neoformans 
as a pathogen is largely attributable to metabolic scavenging during starvation conditions 
within the host’s environment. Lung alveolar macrophages, which are among the first 
immune effectors to combat an initial pulmonary infection, present a glucose- and amino 
acid-poor environment that likely necessitates metabolism of nonpreferred carbon 
sources such as lactate and acetate for establishment of a pulmonary infection.  While 
acetate transporters have been characterized in ascomycetous fungi such as 
Saccharomyces cerevisiae, Candida albicans, Aspergillus nidulans and Yarrowia 
lipolytica the role of acetate production and transport in C. neoformans is not well 
understood and its importance in infection has not been established. Putative acetate 
transporter genes, designated as ADY2 and ATO2, from the GPR1/FUN34/YAAH family 
have been identified in C. neoformans and are highly expressed during infection in the 
lung and during growth on acetate as sole carbon source. Studies have identified acetate 
as one of the metabolites in brain tissue biopsies of infected rats and in culture 
supernatant. We propose that Ady2 and Ato2 have a role in acetate transport as a 
metabolic adaptation during starvation and stressful environmental conditions. Growth of 
the ady2 single mutant, and the ady2ato2 double mutant, but not ato2 single mutant, was 
severely impaired in 1 mM versus 10 mM acetate plates, suggesting that Ady2 is the 
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essential acetate importer during growth on low acetate. Intensity of growth defects was 
emphasized by a 137-fold overexpression of ADY2 during growth on acetate in relation to 
growth on glucose. The role of Ato2 during prolonged starvation was highlighted by 
diminished acetate uptake in the ato2 single mutant after glucose-grown cells were 
passaged into minimal media with acetate as sole carbon source. This study also 
uncovered a role of Ady2 and Ato2 in ammonia export and that they preferentially import 
acetate versus other carboxylates. Major C. neoformans virulence factors: growth at 37°C 
and capsule synthesis were impaired by loss of Ady2 and Ato2. Moreover, Ady2 and 
Ato2 were essential for virulence in mice such that ady2ato2 infected mice survived as 
long as uninfected controls. Additionally, Ady2 and Ato2 were additively required during 
coculture with human and mouse-derived phagocytes. Therefore, acetate transporters 
play a significant role in the survival and virulence of C. neoformans. 
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CHAPTER ONE: LITERATURE REVIEW 
Global disease burden and control of Cryptococcus neoformans 
The annual incidence of cryptococcal meningitis between 1997 and 2007 was 
estimated at 720,000 in Sub-Saharan Africa, 100,000 in Southeast Asia, 50,000 in Latin 
America, 20,000 in Europe and Central Asia and 5,000-20,000 in North America, the 
Caribbean, East Asia, Oceania, North Africa and the Middle East (Sloan and Parris, 
2014). Of these cases, over 600,000 annual deaths occurred due to cryptococcosis, the 
bulk of which were in Sub-Saharan Africa (Sloan and Parris, 2014). Cryptococcus 
neoformans var grubii (capsular serotype D) is the most common subtype, causing 82 % 
of the global manifestation of cryptococcosis. The capsular serotype A (var neoformans) 
on the other hand is prevalent among the northern European (France, Italy and Denmark) 
HIV-infected population at a rate of up to 30 % (Franzot et al., 1999; Dromer et al., 1996; 
Tortorano et al., 1997). According to reports from the US (Pappas et al., 2001) and South 
East Asia (Lui et al., 2006), serotype D has been seen at higher incidence among the 
immunocompetent than serotype A. Unlike Cryptococcus neoformans, Cryptococcus 
gattii (serotypes B and C) are usually diagnosed among the immunocompetent with 218 
cases having been identified on Vancouver Island between 1999 and 2010 (Sloan and 
Parris, 2014).  
Most patients who develop cryptococcosis have defects in cell-mediated 
immunity, specifically in CD4+ lymphocytes. Immune compromisation from AIDS 
predisposes these patients to secondary infections, with cryptococcosis being a leading 
cause of mortality as it has death rates ranging from 15-20 % in the US and 55-70 % in 
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Latin America and sub-Saharan Africa (Park, 2009). Solid organ transplant patients 
receiving immunosuppressive therapy are also at risk of C. neoformans infection. 
Cryptococcosis is the third most common invasive fungal infection in recipients of sold 
organ transplant (Neofytos et al., 2010; Pappas et al., 2010). Recent studies suggest that 
smoking, oral corticosteroids, and older age increase the risk of infection (reviewed in 
MacDougall, 2011). 
Serotyping and diagnosing Cryptococcus infection 
The biochemical characteristics conferred by the sugar envelope of Cryptococcus 
cells enables its grouping into serotypes, A, B, C, D (Kwon-Chung et al., 1982) and AD 
(Cherniak and Sundstrom, 1994; Okabayashi et al., 2006). This is done according to their 
respective antibody agglutination to antigens against the polysaccharide capsule. 
Specifically, the antigenic potential of the capsule is attributable to GXM (consists of 
polymerized mannose, xylose, glucuronic acid and O-acetyl galactoxylomannan 
(GalXM), and mannoprotein (MP) (Cherniak and Sundstrom, 1994). Specific patterns of 
immunological reactions are detectable in response to GXM and its conjugates. Serotypes 
A (mating type a) and D (mating type α) are two of three variants of Cryptococcus 
neoformans and their GXM antigens are conjugates such that one of their six O-acetyl 
groups (the O-2 group) is substituted with beta-D-xylopyranosyl groups. The AD 
Cryptococcus neoformans serotype is aneuploid or diploid and is heterozygous at the 
mating type locus with both the a and α mating alleles (Lengeler et al., 2001). The 
Cryptococcus gattii serotypes B and C are substituted with beta-D-xylopyranosyl at their 
O-2 and O-4 O-acetyl groups (Cherniak and Sundstrom, 1994). 
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Symptomatic cryptococcal patients may present with cutaneous lesions, cough, 
dyspnea, pulmonary ausculatory sounds, fever, fatigue, headache, stiff neck, papilledema, 
blurred vision, confusion and seizures (Darras-Joly et al., 1996; Barron and Madinger, 
2008). To determine suspected infection, such clinical specimens as spinal fluid from 
lumbar puncture, tissue biopsies with granulomata and aspirates from skin lesions 
(Mitchell and Perfect, 1995), are stained with India ink, mucicarmine, Alcan Blue, 
Fontana-Mason silver, Gomor’s methenamine or Calcofluor White then observed by light 
or fluorescent microscopy to detect yeast cells (Mustafa et al., 2014). From patient urine, 
serum and cerebrospinal fluid, cryptococcal capsular antigens can be sensitively detected 
and serotyped (Mitchell and Perfect, 1995).  
Serological tests can accurately detect and quantify solubilized capsule antigens 
by agglutination with rabbit anti-C. neoformans-antiserum (Neill et al., 1951; Nogueira et 
al., 2017). Moreover, urine and blood specimens can be cultured for isolation of C. 
neoformans especially when fungal load is high as is typical of infection in the 
immunosuppressed host (Speed and Dunt, 1995). A suspected C. neoformans culture is 
usually substantiated by melanized yeast colony morphology on Staib’s birdseed agar or 
caffeic acid medium (Staib, 1962). A rapid urease test can also presumptively indicate C. 
neoformans infection (Canteros et al., 1996). While standard mycological techniques can 
diagnose cryptococcosis to the species level, several molecular-based techniques have 
been used to distinguish strains and serotypes by conventional and real time PCR (Sidrim 
et al., 2010), random fragment length polymorphism, random amplified polymorphic 
DNA, and using specific probes and primers (Mitchell and Perfect, 1995). Chest 
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radiographs can be utilized to visualize lung colonization. 
Anticryptococcal therapy 
Despite mortality rates as high as malaria and a high global impact of the annual 
disease burden, investment in research and development towards anticryptococcal agents 
is less than 0.5 % of the global 2014 research and development funding (Moran et al., 
2015; Rodrigues, 2016). The fungicidal polyene amphotericin B is a potent broad-
spectrum antifungal agent (Odds et al., 2003). It binds to ergosterol, an abundant sterol in 
fungal membranes, causing leakage of cytoplasmic contents. However, despite structural 
distinction between fungal ergosterol and mammalian cholesterol, amphotericin B is 
prone to low selectivity of ergosterol over cholesterol causing toxicity to mammalian 
cells, especially nephrotoxicity (Odds, et al., 2003). Liposomal formulations of 
amphotericin B reduce nephrotoxicity by slowing its delivery rate to the kidneys (Odds et 
al., 2003).  
Another effective anticryptococcal agent is the fluorinated pyrimidine analogue, 
5-flucytosine. Its antifungal action is such that flucytosine is converted to 5-fluoroacil (5-
FC) that is incorporated into fungal RNA, thus prematurely terminating transcription. 
Fungal cytosine permease catalyzes uptake of flucytosine, cytosine deaminase converts it 
to 5-FC and uracil phosphoribosyl transferase converts it to a substrate fit for synthesis of 
nucleic acids. 5-flucytosine also inhibits DNA synthesis by perturbing the function of 
thymidylate synthase. 5-flucytosine has excellent delivery due to good penetration even 
into cerebrospinal fluid (Odds et al., 2003). However, resistance to flucytosine has been 
reported due to mutations in fungal cytosine permease, deaminase, and phosphoribosyl 
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transferase (Odds et al., 2003). 
The gold standard therapy for treatment of cryptococcosis is a combination of 
amphotericin B and 5-flucytosine (Krysan, 2015). Both amphotericin B and 5-flucytosine 
were discovered over half a century ago, yet it is only recently that a clinical trial 
demonstrated that the combination therapy is better than amphotericin B alone (Day et 
al., 2013). Not only is this gold-standard anticryptococcal therapy too costly to be made 
available in resource poor countries, which have the highest mortality from the infection, 
it also has an associated toxicity such that only 37 % of patients at a major medical center 
in the United States receive this combination therapy (Perfect, 2013).
The azoles (fluconazole, miconazole, ketoconazole, itraconazole) are a class of 
antifungal agents that function by perturbing membrane permeability and fluidity by 
depleting ergosterol. However, resistance has been reported due to mutations that alter 
cytochrome P450-Erg11 or Cyp51p, which are the targets for mode of action of these 
azoles (Odds et al., 2003). Due to economical constraints that preclude access to the gold 
standard anticryptococcal therapy, fluconazole is still the readily available 
anticryptococcal drug used in resource poor countries. Echinocandins are the newest class 
of antifungal drugs which were identified forty years ago then made available on the 
market twenty years afterwards (Espinel-Ingroff, 1998; Tawara et al., 2000). The 
echinocandins include caspofungin, micafungin, and anidulafungin, impede synthesis of 
fungal β1,3-glucan, a major component of the fungal cell wall, by inhibiting function of 
β1,3-glucan synthase, which catalyzes glucose polymerization through β1,3 linkages. 
However, C. neoformans is resistant to caspofungin both in vitro and in vivo (Maligie and 
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Selitrennikoff, 2005). 
High drug toxicity and mounting cryptococcal resistance to antifungals are the 
main challenges that undermine treatment of both pulmonary and disseminated 
cryptococcosis. This challenge is further complicated by the characteristic 
immunocompromised state of most patients; hence relapse of infection despite stringent 
therapy (Odds, et al., 2003; Mitchell and Perfect, 1995). These challenges create urgency 
for a deeper understanding of indispensable virulence-associated genes, which could 
provide an effective target for anticryptococcal therapy.  
Cryptococcus neoformans host-pathogen interactions 
The host inhales the environmentally ubiquitous C. neoformans’ desiccated 
cryptococcal cells or basidiospores. For progression to the lungs, C. neoformans cells 
must overcome the host’s relatively elevated temperature of 37°C. Moreover, the 
pathogen must traverse the initial physical host barriers: skin and nasal mucosa (Rohatgi 
and Pirofski, 2015). With the aid of mucociliary movement and gravity, C. neoformans 
reaches the lungs causing pulmonary cryptococcosis (Figure 1-1) (Sabiiti and May, 
2012). The cryptococcal cells then adhere to the host’s pulmonary epithelial cells. This is 
promoted by the host’s lung surfactant, which facilitates cryptococcal cells’ opsonization, 
therefore enhancing phagocytosis by macrophages (Ganendren et al., 2006). An intact 
immune system responds with activated macrophages (AMΦ) killing or containing the 
infection in a granuloma (Figure 1-1). CD4 T cells can also recruit macrophages and 
granulocytes to sites of pulmonary infection (Huffnagle et al., 1994). In the absence of 
antigen stimulation, memory B cells also produce IgM which enhances innate immunity 
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by containing C. neoformans in alveolar macrophages and reducing its dissemination 
with a predilection to the host’s brain (Rohatgi and Pirofski, 2012).  
In opposition to host phagocyte activation, cryptococcal cells synthesize capsule 
and melanin which are protective against reactive oxygen species secreted by immune 
cells and phosphoglycerate E (PGE) downregulates host antimicrobial activity (Valdez et 
al., 2012). C. neoformans also upregulates its nutrient and ion acquisition (Ctr4-copper 
acquisition, Cft1/Cfo1-iron acquisition) to facilitate their survival in the nutrient poor 
lung environment (Hu et al., 2008). Resistance to harsh environments complicates 
cryptococcal clearance as the cells can survive and proliferate within the macrophages 
(Tucker and Casadevall, 2002). Should the patient’s immunity become compromised, 
latent cryptococci in granulomas or engulfed in parasitized macrophages (PMΦ) can get 
reactivated and enter systemic circulation by riding in the PMΦ or non-lytically exiting 
into blood circulation, hence fungemia (Figure 1-1).  
Alternatively, C. neoformans could grow into large cells that are refractory to 
phagocytosis and enter systemic circulation (Figure 1-1). The complement system is an 
essential anticryptococcal armour, substantiated by complement-deplete patients having 
characteristic higher fungaemea (Macher et al., 1978) and complement-sufficient animals 
being more resistant to cryptococcosis (Rhodes and Wicker, 1980). Cell-mediated 
immunity in concert with either the complement system or Fc-γ receptors of 
macrophages, dendritic cells and neutrophils also facilitate cryptococcal containment and 
clearance by phagocytosis of complement-opsonized yeast (Levitz and Tabuni, 1991); 
and binding to antibody-opsonized C. neoformans respectively (Griffin, 1981). Natural 
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killer (NK) cells have perforin-mediated anti-cryptococcal activity (Ma et al., 2004). Host 
resistance to C. neoformans is also mediated by secretion of IL-4 and IFN γ production, 
and Th1 pro-inflammatory cytokine responses following activation of NK T cells 
(Taniguchi et al., 2003). In the event of exaggerated anti-inflammatory response, the γδ T 
cells secrete anti-inflammatory Th2 cytokines to regain balance (Uezu et al., 2004). 
Activated CD8 T cells also secrete IFN γ production that inhibits growth of C. 
neoformans inside macrophages (Lindell et al., 2005).  
The host’s adaptive immunity elicits protective activation against such 
cryptococcal antigens as the GXM capsule, cell wall polysaccharides, and specific 
cryptococcal proteins. When patients were vaccinated with a GXM vaccine conjugate 
formulated to a T-dependent antigen, the GXM-tetanus toxoid (GXM-TT), IgG2 was 
found to be protective by enhancing phagocytosis by human mononuclear cells (Zhong 
and Pirofski, 1996). Moreover, a mouse monoclonal GXM IgG1 (mAB18B7) was 
promising as an approach to cryptoccocal meningitis treatment among HIV-infected 
patients at a phase 1 trial, which unfortunately lacked resources hence failed to proceed 
(Casadevall et al., 1998; Larsen et al., 2005). For a cryptococcal meningitis outcome, C. 
neoformans traverses the blood-brain barrier by (Figure 1-1): A) entry between 
endothelial cells, enhanced by damage to tight junctions facilitated by phospholipase B 
(PLB) which is degradative to membranes (Stie et al., 2009); B) adhering to brain 
microvascular endothelial cells (BMECs) and being internalized (Shi et al., 2010); or C) 
riding in parasitized immune cells such as PMΦ, hence the "Trojan horse" model of 
dissemination (Charlier et al., 2009; Sabiiti and May, 2012; Santiago-Tirado et al., 2017).  
 9 
Dissemination to the brain results in cryptococcal meningoencephalitis, whose 
mortality in some populations can reach 100 % regardless of immune status and despite 
administration of antifungals (Mwaba et al., 2001; Lee et al, 2011). During disease 
progression of C. neoformans in the host, the pathogen encounters a variety of 
environments ranging from a glucose-limited, slightly acidic alveolar macrophage 
environment (Vylkova and Lorenz., 2014; Cox et al., 2003; Nyberg et al., 1992; Barelle 
et al., 2006), which mimics growing on acetate as a sole carbon source (Lorenz et al., 
2004), to the more glucose-rich (0.1 %) and slightly alkaline conditions of the blood 
(O’Meara et al., 2010; Güemes et al., 2016). Glucose level in the brain is maintained at 
approximately 0.1 % - 0.2 % (Gruetter et al., 1992) at a slightly alkaline pH (O’Meara et 
al., 2010). (Figure 1-1).  
Virulence determinants of Cryptococcus neoformans 
Several traits that influence the degree of pathogenicity of C. neoformans have 
been extensively reviewed (Coelho et al., 2014; Kronstad et al., 2012). The three major 
virulence determinants are: ability to grow at 37°C, a polysaccharide capsule, and 
melanin formation (Coelho et al., 2014; Kronstad et al., 2012). To successfully cause 
disease, C. neoformans has to be able to grow at 37°C, which is uncharacteristic of such 
non-pathogenic strains as soil fungi (Coelho et al., 2014). The ability of C. neoformans to 
sense the environment and adjust to environmental stresses such as temperature is 
facilitated through signal transduction cascades such as the calcineurin pathway (Odom et 
al., 1997; Lengeler et al., 2000). The capsule is another major virulence determinant of C. 
neoformans (Kwon-Chung and Rhodes, 1986). Cell wall associated and secreted capsule 
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polysaccharides are immunomodulatory as exported capsule-associated mannoproteins 
stimulate T-cell mediated immune response. Acapsular mutants are typically avirulent 
except in the event of extreme immunosuppression (Kronstad et al., 2012). Moreover, the 
smaller the capsule size the more efficient the phagocytosis and clearance of cryptococcal 
cells by macrophages (Bojarczuk et al., 2016). Deposition of melanin in the cell wall 
poses an additional influence to the degree of pathogenicity of C. neoformans (Kwon-
Chung and Rhodes, 1986). Cryptococcal cells synthesize melanin from catecholamine 
substrates with the aid of copper-dependent laccases (Eisenman and Casadevall, 2012; 
Almeida et al., 2015). The central nervous system is catecholamine rich and experimental 
evidence suggests that cryptococcal cells synthesize melanin within brain cells 
(Norsanchuk et al., 2000). Melanin confers protection to C. neoformans cells against 
antifungal agents, environmental radiation, and oxidative killing by phagocytes thus 
facilitating dissemination (Coelho et al., 2014; Kronstad et al., 2012) beyond the initial 
site of infection (lung colonization).  
C. neoformans cells also secrete neutralizing enzymes and metabolites, among
them enzymes conferring resistance to oxidative and nitrosative stress. Upon the loss of 
these enzymes, virulence is attenuated and susceptibility to killing by phagocytes is 
facilitated (Missal et al., 2006; Coelho et al., 2014; Broxton and Culotta, 2016). Cell wall 
localized laccases and phospholipase B are important enzymes classified as virulence 
factors that facilitate melanin formation, cell wall integrity, and dissemination of 
cryptococcal cells to extrapulmonary sites (Noverr et al., 2004; Coelho et al., 2014). 
Urease enzyme secretion is another important virulence-associated trait of C. 
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neoformans, which facilitates its crossing the blood-brain barrier following urea 
breakdown into ammonia and carbamate, thus raising the local pH (Cox et al., 2000; 
Olszewski et al., 2004). This increased pH has been suggested to cause toxicity to 
endothelial cells hence facilitating permeability of cryptococcal cells and their crossing 
the blood brain barrier (Shi et al., 2010).   
Role of fungal acetate metabolism in Cryptococcus neoformans pathogenesis 
Gene expression profiling during murine pulmonary infection revealed induction 
of the glyoxylate pathway, fatty acid beta-oxidation, gluconeogenesis and amino acid 
synthesis. The resident lung alveolar macrophages, which present an initial immune 
response against C. neoformans infection (Feldmesser et al., 2000; Feldmesser et al., 
2001), have a characteristically glucose- and amino acid-poor environment (Barelle et al., 
2006; Lorenz et al., 2004). Consequently, such nonpreferred carbon sources as lactate and 
acetate may be important for nutrient scavenging early in establishment of pulmonary 
infection (Price et al., 2011). It was therefore hypothesized that carbon-source limitation 
was experienced by C. neoformans thus requiring alternative carbon source scavenging 
(Hu et al., 2008).  In agreement with this hypothesis, elevated transcript levels of the 
putative acetate transporters, ADY2 (CNAG_05678) and ATO2 (CNAG_05266), as well 
as the gene encoding acetyl-CoA synthetase (ACS) in infected mice led to a speculation 
that acetyl-CoA production provided a precursor for central carbon metabolism in C. 
neoformans during starvation.  
Acs is generally considered to operate solely in the direction of acetate activation 
to acetyl-CoA during which it utilizes up ATP and CoA to form AMP and PPi in C. 
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neoformans (Ingram-Smith, et al., 2006). An acs mutant was attenuated in virulence and 
could not utilize acetate as the sole carbon source (Hu et al., 2008). Furthermore, the 
virulence-associated role of O-acetylation of cryptoccocal capsule and cell wall chitin 
synthesis was suggested (Hu et al., 2008).  The yeasts Candida albicans and 
Saccharomyces cerevisiae have two isoforms of Acs, termed Acs1 and Acs2. Cytosolic 
acetyl-CoA is likely generated by Acs2 during glucose utilization (Berg and Steensma, 
1995; Carman et al., 2008). When growing on highly assimilable carbon sources such as 
glucose, fungi glycolytically execute either oxidative respiration or nonoxidative 
fermentation, with production of NAD+ being far more efficient using the former route. 
As eukaryotes are typically facultative or obligate aerobes, aerophilic respiration occurs 
unless oxygen is depleted (Strijbis and Distel., 2010). For example, C. albicans 
glycolytically oxidizes glucose to pyruvate in the cytosol followed by further oxidization 
to CO2 through the TCA cycle in the mitochondria. Like in prokaryotes, the C. albicans 
pyruvate dehydrogenase complex (Pda) evolves pyruvate to acetyl-CoA. The Pda 
associates to the mitochondrial membrane and acetyl-CoA once produced, gets released 
within the mitochondria where it remains until glucose becomes limiting (Strijbis and 
Distel., 2010).  
Besides Acs, two other pathways involved in production of cytosolic acetyl-CoA 
were induced during pulmonary infection of mice with C. neoformans (Figure 1-2). 
Beta-oxidation multifunctional enzyme type 2 (Mfe2), which is an integral part of 
utilization of storage lipids and exogenous fatty acids to generate acetyl-CoA, was 
induced during pulmonary infection of mice (Hu et al., 2008). Mutants lacking Mfe2, 
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which catalyzes the second and third steps in peroxisomal fatty acid beta-oxidation, were 
defective in growth on fatty acids and acetate, melanin biogenesis and capsule formation, 
and had attenuated virulence (Kretschmer et al., 2012). Furthermore, a double deletion 
mutant of the genes encoding Mfe2 and hydroxyacyl-CoA dehydrogenase (Had1), which 
catalyzes the third step in mitochondrial beta-oxidation, resulted in full attenuation of 
virulence (Kretschmer et al., 2012). ATP-citrate lyase (Acl1), which converts citrate to 
acetyl-CoA, is the third source of cytosolic acetyl-CoA. Expression of ACL1 is 
upregulated during macrophage coculture (Griffiths et al., 2012) and its loss resulted in 
capsule defect during growth on low iron medium (LIM) which contained 0.5 % glucose. 
However, upon replacing glucose with 0.5 % acetate, the capsule defect was rescued. 
This suggested a requirement of Acl1 for attainment of the threshold of capsule 
acetylation in the absence of acetate that would allow for its correct attachment. Loss of 
Acl1 also affected melanization in the absence of acetate. The mutants lacking Acl1 were 
altogether avirulent, had significantly low pulmonary fungal load, and had diminished 
dissemination into the BALB/c mouse brain (Griffiths et al., 2012).  
The eukaryotic nature of fungi presents an additional layer of complexity: unlike 
prokaryotic cells, acetate metabolic pathways in such fungi as C. albicans and S. 
cerevisiae are compartmentalized in the nucleus, peroxisome, mitochondria and cytosol. 
Nuclear acetyl-CoA is the donor of acetyl units for histone acetylation (Takahashi et al., 
2006) that directly impacts replication, DNA repair, transcription, cell cycle progression, 
and aging (Galdieri et al., 2014). Intracellular acetate transport within respective 
organellar sources is governed by inter-conversion of metabolite intermediates into 
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variants that are least toxic and easily transported across membranes. Acidity of acetate 
and other carboxylates could lower intracellular pH to toxic levels, thus necessitating 
detoxifying transport and conjugation mechanisms. The amphiphilic nature of cytosolic 
acetyl-CoA precludes its ability to diffuse across a membrane, particularly from the 
cytosolic pool into the mitochondria. To circumvent this, the activated acetyl group is 
transferred from CoA to carnitine by the carnitine acetyltransferase (Cat). The activated 
carnitine is then transported by an acetyl-carnitine/carnitine translocase (Cact) then 
reverted back to acetyl-CoA inside the mitochondria where it feeds into the TCA cycle 
for subsequent ATP generation. The two-carbon acetyl-CoA can also be a precursor for 
synthesis of sugars following production of four carbon intermediates through the 
glyoxylate pathway that allows fungal growth on non-fermentable carbon sources. This 
gives fungi the unique advantage of being able to subsist on fatty acids as the sole carbon 
source.  
Mitochondrial acetyl-CoA hydrolases (Ach) in S. cerevisiae and Neurospora 
crassa are involved in detoxification of mitochondrial acetate by transferring CoASH 
from succinyl-CoA to acetate such that the energy intensive hydrolysis of acetyl-CoA is 
bypassed and instead mitochondrial acetate is detoxified (Buu et al., 2003; Fleck et al., 
2009). Peroxisomal acetyl-CoA in C. albicans and S. cerevisiae is generated following 
oxidation of acyl-CoA during beta-oxidation of fatty acids by acyl-CoA oxidases and 
ketoacyl-CoA thiolases (Strijbis and Distel., 2010).  
Not only is acetate among the most abundant metabolites recovered in culture 
supernatants during growth in glucose (Bubb et al., 1999), it has also been identified as 
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one of the most abundant metabolites in brain tissues of infected rats following 
cryptococcal dissemination through the blood-brain barrier (Himmelreich et al., 2003). 
Export of acetate among other carboxylic acids has been proposed to acidify the 
extracellular environment leading to altered chemotaxis of phagocytes towards 
cryptococcal cells, and induction of neutrophil necrosis (Wright et al., 2002). Genes 
encoding proteins involved in acetate production: pyruvate decarboxylase (Pdc), 
aldehyde dehydrogenase (Ald), xylulose 5-phosphate/fructose 6-phosphate 
phosphoketolase (Xfp) were induced during pulmonary infection by C. neoformans (Hu 
et al., 2008; Kronstad et al., 2012). Smith and coworkers (Ingram-Smith, et al., 2006) 
have identified two putative acetate-producing pathways (Figure 1-3), whose genes have 
been found to be upregulated during mice pulmonary infection (Hu et al., 2008). One 
pathway, previously thought to be present only in bacteria, consists of acetate kinase 
(Ack) partnering with xylulose 5-phosphate/fructose 6-phosphate phosphoketolase (Xfp) 
in a modification of the pentose-phosphate pathway to produce acetate from ketose 
sugars with the formation of ATP. The Ack-Xfp pathway is found in euascomycetes and 
some basiodiomycetes but is absent in yeasts such as S. cerevisiae and C. albicans 
(Ingram-Smith, et al., 2006).  
The second possible acetate production pathway, pyruvate decarboxylase (Pdc) 
and acetaldehyde dehydrogenase (Ald), decarboxylates pyruvate to acetaldehyde, which 
is then oxidized to acetate in the presence of NADP+ (Hu et al., 2008; Tielens et al., 
2010). A third possible source of acetate in C. neoformans could be Acs. Upon 
acetylation of an unidentified lysine residue(s), Aspergillus nidulans Acs has been shown 
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to have increased affinity to acetyl-CoA, consequently catalyzing the reverse reaction to 
produce acetate and ATP in an acetyl-CoA dependent fashion under conditions of 
ammonia fermentation (Takasaki et al., 2004).  
Acetate metabolism is also conserved among the prokaryotes. During exponential 
growth on preferred carbon sources such as glucose, bacteria excrete acetate and other 
carboxylic acids as part of their byproducts, which lowers extracellular pH (Wolfe, 
2005). However, as these bacterial cells deplete the preferred carbon sources, growth 
slows down resulting in a switch to utilization of alternative carbon sources like acetate 
and catabolism of amino acids to produce ammonia. Consequently, the media becomes 
alkalinized (Prüß et al., 1994; Chang et al., 1999). Research substantiates that 
phosphorylation of acetyl units emanating from catabolism of glucose acts to signal a 
switch to metabolism of acetate and has regulatory consequences as far reaching as 
nitrogen assimilation, capsule synthesis, biofilm generation, and overall pathogenicity 
(Wolfe, 2005). In Escherichia coli, acetate production from breakdown of highly 
assimilable carbon sources serves to produce high energy ATP for the cell, restore NAD+ 
spent during glucose catabolism by glycolysis and to recycle coenzyme A which is 
utilized upon (non)oxidative decarboxylation of pyruvate to acetyl-CoA, which could be 
fed into the TCA cycle and fully oxidized into CO2 (Wolfe, 2005).  
Despite conserved acetate producing pathways among both eukaryotic and 
prokaryotic microorganisms, a few pathways remain exclusively prokaryotic. Glycine 
metabolism is one such pathway among Gram positive bacteria like Clostridium and 
Eubacterium, resulting in acetyl phosphate formation, catalyzed by glycine reductase 
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(Stadtman and Davis 1991; Schräder and Andreesen, 1992; Wolfe, 2005). Overall, acetyl 
phosphate has been documented in E. coli to regulate acetylation of lysine peptide 
residues to regulate cell growth signaling (Weinert et al., 2013). A conserved lysine (609) 
residue of Salmonella enterica Acs inhibits its activity when acetylated (Starai et al., 
2002) and this residue is conserved in S. cerevisiae, a lower eukaryote (Starai et al., 
2003). Moreover, the deacetylated form of E. coli Acs is more active than its acetylated 
counterpart (Castaño-Cerezo et al., 2014). Across bacteria (excluding E. coli) catabolism
of sulfonated compounds yields a key intermediate, sulfoacetaldehyde, which can be 
further evolved by the enzyme sulfoacetaldehyde acetyltransferase into acetyl phosphate 
and sulfite (Jürgen and Denger., 2003). Under glucose-derepressed conditions, acetate 
utilization helps cells scavenge for energy. Primarily, Acs is induced during low acetate 
(Brown et al., 1977; Kumari et al., 1995). This pathway catalyzes production of acetyl-
CoA, PPi and AMP from acetate, ATP and CoA under limiting acetate concentrations as 
excess acetate could drive the Ack-Pta pathway in the acetyl-CoA forming direction 
(Wolfe, 2005). 
Export and uptake of weak carboxylic acids 
Weak carboxylic acids such as pyruvate, acetate, and lactate accumulate during 
growth on highly assimilable carbon sources. These carboxylic acids dissociate partially 
in aqueous systems and exist in a pH-dependent equilibrium between the uncharged 
protonated and charged deprotonated forms of the acids (Casal et al., 2008). Since 
intracellular cytosolic pH is buffered at neutral-slightly alkaline while the pKa of acetate 
is 4.76, acetate dissociates to its deprotonated form, which confers an osmotic challenge 
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to the cell. Furthermore, the dissociated proton could be toxic as it rapidly acidifies the 
cytosol with the risk of inducing programmed cell-death (Giannattasio et al., 2013). 
Therefore, ability to activate acetate to acetyl-CoA relieves the cell of this toxicity 
challenge while providing an alternative carbon source. During growth on excess glucose 
and when acetate levels exceed the cells potential and need of activation, an export 
strategy becomes necessary.  An ATP-binding cassette (ABC) efflux pump, Pdr12 from 
the Pleiotropic Drug Resistance (PDR) Subfamily is involved in efflux following 
induction by sorbic, benzoic, propionic acids and slightly by acetate in S. cerevisiae 
under the control of the War1p transcription factor (Holyoak et al., 1999; Piper et al., 
1998; Piper, 2011). To counter the continued diffusion of acetate into the cell along a 
concentration gradient, which would cost cellular ATP to export, yeast cells remodel their 
membrane to diminish its porosity (Simoes et al., 2006). Little else is known of acetate 
efflux proteins. 
As cells gradually deplete the preferred carbon sources, a switch to catabolism of 
the partially oxidized carboxylic acids generated through breakdown of the highly 
assimilable carbon sources is executed (Wolfe, 2005; Casal et al., 2008). Extracellularly 
secreted carboxylic acids exist in protonated and deprotonated forms relative to 
environmental pH. At a pH above their pKa, carboxylic acids are mostly deprotonated 
but stay associated and uncharged when the pH is below their pKa. These forms of 
carboxylic acids call for either of two transport mechanisms, the first being passive 
transport, which occurs by either i) simple diffusion or ii) facilitated diffusion using a 
permease or through a channel. Below their pKa, weak carboxylic acids exist in an 
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uncharged protonated form, which is lipid-soluble and can traverse membranes by simple 
diffusion. The neutral intracellular pH favors the charged, deprotonated form of the acid 
that is lipophobic and cannot readily diffuse outside the cell (Casal et al., 2008).  
Experimental evidence in S. cerevisiae has identified Fps1p, a membrane 
aquaglyceroporin channel through which undissociated acetate traverses the membrane. 
Mutants lacking Fps1p accumulate acetate slower than wild type cells and are more 
resistant to acetate toxicity (Mollapour and Piper, 2007). The second mechanism of 
carboxylic acid transport is active transport, which is typically characterized by the 
charged acid entering the cell against a concentration gradient through a permease that 
acts as a secondary active transporter such as a proton symporter. This is usually 
enhanced by an energy-dependent electrochemical gradient, derived from secondary ions 
like Na+, K+, or H+, which provides energy to shuttle the anion against a concentration 
gradient. As intracellular pH favours accumulation of the anionic acid, a primary active 
transport mechanism that spends ATP usually exports the charged acid by a pump (Casal 
et al., 2008). 
Transport of acetate in bacteria and archaea 
Two acetate transporters have been identified in E. coli. During nutrient 
deprivation, an acetate permease designated Actp is co-induced at the RNA level with 
Acs for scavenging micromolar concentrations of extracellular acetate (Gimenez et al., 
2003). YaaH (SatP) is another acetate-proton symporter that has been characterized in E. 
coli and is competitively inhibited by succinate, hence classified as an acetate-succinate 
transporter with a higher affinity for acetate (Sá-Pessoa et al., 2013). E. coli Actp is a 
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member of the Sodium:Solute Symporter family while E. coli YaaH belongs to the YaaH 
family. This latter transporter functions mainly during exponential growth phase on 
glucose before the cells switch to start assimilating acetate while ActP functions during 
stationary phase once the acetate switch has been executed and the glyoxylate bypass 
activated (Sá-Pessoa et al., 2013). Genome analysis of Geobacter 
sulfurreducens identified four homologs of E. coli ActP (Risso et al., 2008). A 
monocarboxylic acid transporter (MctC) of the same Sodium:Solute Symporter family 
has been identified in Corynebacterium glutamicum as having a high affinity for acetate 
and propionate and a low affinity for pyruvate (Jolkver et al., 2009). 
The first known evidence of acetate permease activity in Archaea was reported in 
Natronococcus occultus following [14C]-acetate uptake assays (Kevbrina et al., 1989). 
Acetate permeases have been identified in methanoarchaea such as Methanosaeta (Smith 
and Ingram-Smith, 2007), and in Methanosarcina spp. such as Methanosarcina mazei 
MM_0903 (Welte et al., 2014). Methanosarcina acetivorans MA4008 homologs are 
highly induced during growth on acetate as sole carbon and energy source and upon their 
loss acetate uptake was impaired (Rohlin and Gunsaulus, 2010). 
Transport of acetate in yeast and fungi 
Two putative acetate transporters, designated as Ady2 and Ato2, from the 
Gpr1/Fun34/YaaH family of acetate transporters, have been identified in C. neoformans 
and are highly expressed during infection in the lung (Hu et al., 2008). Although not 
much else is known about acetate transport in C. neoformans, it has been investigated in 
other fungi. S. cerevisiae ADY2 was shown to be essential for the activity of the 
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membrane transport protein, acetate permease in uptake of acetate and was upregulated 
following a switch of S. cerevisiae from glucose-rich medium to a nutrient-poor medium 
supplemented with acetate (Paiva, et al., 2004). While S. cerevisiae Jen1 is a dedicated 
lactate transporter whose loss abolishes lactate uptake (Pacheco et al., 2012), lactate 
transport can be restored by complementation with Ady2pLeu219Val and Ady2pAla252Gly
suggesting that these altered Ady2p alleles can function to transport lactate (de Kok et al., 
2012). S. cerevisiae is able to actively transport acetate when only acetate or ethanol is 
present in media (Casal, et al., 1996).  
Unlike S. cerevisiae Ady2 (Ato1p), two other homologs Fun34 (Ato2p) and Ato3 
(Ato3p) did not exhibit as drastic an effect in acetate transport; hence their role in acetate 
transport could not be conclusively ascertained (Paiva et al., 2004). A role of all three 
genes in environment alkalinization was proposed following the observation that 
subcellular localization, and ammonia export was consistent with induction of these 
genes (Palková et al., 2002; Řičicová et al., 2007). Consistent with this observation, the 
ady2, fun34, and ato3 deletion mutants had impaired ammonia export (Palková et al., 
2002; Řičicová et al., 2007). Each of these three transporters is distributed differentially 
in ergosterol-rich fractions of the membrane. While Ato2p is diffuse uniformly in the 
membrane, Ato1p and Ato3p are enriched in lipid rafts. However, Ato1p’s localization in 
this fraction is pH-regulated (Řičicová et al., 2007). With the aid of fluorescent life-time 
imaging (FLIM), fluorescent resonance energy transfer (FRET) and photobleaching, 
Strachotová et al., (2012) uncovered physical interactions between three S. cerevisiae 
transporters: Ato1p-Ato2p, Ato1p-Ato1p, Ato3p-Ato3p forming complexes within the 
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membrane. These interactions suggest that these proteins’ functions are not redundant but 
may be synergistic.  
In the euascomycete A. nidulans, the Ady2 homolog AcpA was essential for 
uptake of deprotonated acetate and exhibited acetate permease activity (Robellet, et al., 
2008). When concentration of protonated, uncharged acetate was lower than that of 
deprotonated acid in nutrient-poor media, this acpA mutant had growth defects growth 
rates but it was able to grow to wild type levels when protonated acetate concentration 
was high. Complementation of the acpA knockout with ACPA rescued the mutant 
phenotype (Robellet, et al., 2008). Unlike S. cerevisiae ADY2, the A. nidulans ortholog 
ACPA is not under carbon catabolite repression and is not an ammonia exporter (Sá-
Pessoa et al., 2015). However, short chain monocarboxylates such as benzoate, formate, 
butyrate and propionate competitively inhibit its function (Sá-Pessoa et al., 2015). 
Moreover, site-directed alterations and targeted truncation of parts of the open reading 
frames of the S. cerevisiae Ady2 (Ato1) and Ato2 (Fun34) led to hypersensitivity to 
acetate (Gentsch et al., 2007). Alterations of amino acids in the N-terminus of the yeast 
Yarrowia lipolytica Gpr1p causes hypersensitivity to protonated acetate. However, 
removal of the complete ORF has no such effect. This suggested that Gpr1p is involved 
in adaptation to acetate (Gentsch et al., 2007). The ability to raise pH through ammonia 
export may also play a significant role in adapting to the acidic pH of the phagolysosome. 
In the opportunistic fungal pathogen C. albicans, the ten genes of the ATO family raise 
both macrophage pH and in vitro through ammonia export (Danhof and Lorenz, 2015).  
A pathogen's ability to sense and actively modulate their environment enhances 
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their remarkable ability to prevail despite host attempts to expel them by creating harsh 
microenvironments. Media alkalinization by C. albicans was observed to be virulence 
associated and inhibited by presence of glucose, hence hypothesized to be glucose 
repressible (Vylkova et al., 2011). While little is known about pH modulation in C. 
neoformans, the recovery of acetate during infection, and induction of acetate 
transporters whose homologs in C. albicans have a virulence-associated role in carbon 
source dependent pH modulation, suggest a similar role in C. neoformans. Iron 
acquisition in C. albicans is pH modulated and its limitation is consistent with 
upregulation of homologs of iron transporters. (Thewes et al., 2007).  Iron transporters 
are also elevated during C. neoformans infection, suggestive of iron limitation during 
infection (Hu et al., 2008). 
Role of acetate transport in nutrient sensing and cellular signaling cascades 
SNF1, the yeast ortholog of mammalian Pka, which encodes a cellular energy 
sensor that acts as a master regulator of metabolism, facilitates catabolic pathways during 
energy limitation, and inhibits protein, carbohydrate, lipid biosynthesis, cell growth and 
proliferation (Hardie, 2007). Activation of Snf1 causes ATP production and may 
phosphorylate Gpr1/Fun34/YaaH proteins, thus regulating acetate uptake relative to 
cellular acetyl-CoA needs. Additionally, the SNF1/PKA pathway controls nucleosome 
structure and remodeling at the ADY2 promoter as evidenced by abolished H3 acetylation 
at the -1 and +1 nucleosomes in a SNF1 deletion mutant (Abate et al., 2012). Moreover, 
accumulation of ADY2 mRNA was diminished in this mutant, suggesting an interaction 
between Ady2 and Snf1 (Abate et al., 2012). Similarly, acetate regulates S. cerevisiae 
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sporulation under the control of cAMP/PKA pathway in a pH-dependent manner 
(Jungbluth et al., 2012). Sporulation occurs following nutrient limitation that induces 
meiosis and ultimate nuclear packaging into compact spores (Neiman., 2011).  
Evidence of ADY2 involvement in cell cycle progression during meiosis was 
demonstrated in S. cerevisiae by Young et al., (2003) under the control of Adr1, a carbon 
source responsive transcriptional regulator that impacts induction of pathways which feed 
into the cellular acetyl-CoA pool, and requires upstream function of Snf1. Moreover, 
cAMP/PKA signaling is connected with the pH responsive transcription factor, Rim 101 
which is required for correct capsule anchoring onto the C. neoformans cell surface and 
mutants lacking Rim 101 were defective in growth during alkaline conditions (Kronstad 
et al., 2011a). Pathogenic fungi characteristically induce virulence associated traits during 
growth in physiological pH, consequently mutants lacking Rim101 or other interacting 
factors such as Nrg1, a predicted transcription factor which is also regulated by 
cAMP/Pka pathway, are also defective in virulence (Alkan et al., 2013). Moreover, a high 
pH generally affects nutrient bioavailability relative to charge and transmembrane 
diffusibility, thus necessitating mechanisms of facilitated nutrient uptake (Kisirkoi et al., 
unpublished). 
Due to a link between Snf1 protein complex’s regulation of acetyl-CoA levels, 
nutrient sensing and epigenetic gene regulation (Zhang et al., 2013), one might expect 
that acetate uptake is coupled with a cellular signal transduction mechanism that allows 
the cell to master-regulate its physiological processes using acetyl-CoA levels from 
acetate metabolism. The induction of S. cerevisiae (Paiva et al., 2004) and A. nidulans 
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(Robellet et al., 2008) acetate transporters to utilize acetate may be contributing to 
fluctuations in the acetyl-CoA pool. As a result, there may be an interaction with adenylyl 
cyclase such that the consequent production of cyclic AMP (cAMP), a ubiquitous 
messenger of extracellular signals, leads to activation of an AMP activated protein kinase 
A (Pka) (Figure 1-4).  
In the Y. lipolytica Gpr1p, Ser-37 is reversibly phosphorylated in the presence of 
acetate but not glucose (Gentsch et al., 2005). This fluctuating pool of cellular acetyl-
CoA impacts cellular metabolic expenditures and the virulence-associated capsule 
acetylation thus undermining capsule attachment, histone acetylation and cell cycle arrest 
(Galdieri et al., 2014). From our review of literature on roles played by fungal 
Gpr1/Fun34/YaaH family members, we present a model (Figure 1-4) that is supported 
further by Alspaugh et al., (2002) who also demonstrated that C. neoformans adenylyl 
cyclase and its second messenger, cAMP are integral to capsule and melanin formation, 
two key virulence factors, and virulence in a mouse model.  
Chapter summary 
The first chapter serves to provide readers with a broad understanding of the 
disease burden associated with cryptococcal meningitis and to demonstrate a link 
between C. neoformans pathogenicity and acetate metabolism and transport. The 
discussions in this chapter further evaluate functional and translational analyses of acetate 
transport and their pertinent proteins. Chapter 2, goes deeper into expounding on a 
functional analysis of C. neoformans acetate transporters as studied and provides 
experimental evidence of C. neoformans Ady2 and Ato2 of involvement in and 
 26 
requirement for acetate transport. Further, Chapter 3 delineates the role of acetate 
transport in pathogenesis of C. neoformans. In Chapter 4, we provide experimental 
details and evidence for the roles of Ady2 and Ato2 in virulence in an invertebrate model, 
Galleria mellonella. Experimental detail on Ady2 fluorescent tagging are provided in 
Chapter 5 followed by applications of yeast protein isolation and western blotting 
techniques to investigate the construct. Chapter 6 provides inferences of our overarching 
findings while highlighting opportunities for continued investigations. 
Why study acetate transport in Cryptococcus neoformans? 
Despite an importance of acetate transport and metabolism during C. neoformans 
infection, knowledge of acetate transport in this pathogen is still very limited. Acetate 
transport during infection by C. neoformans could provide an anticryptococcal target 
against this pathogen that causes a significant annual death toll of an increasingly global 
reach. Current treatment regimens against C. neoformans are challenged with developing 
drug resistance and toxicity to patients, hence the need for alternative drug targets. 
Identification of Ady2 as a putative acetate transporter upregulated during C. neoformans 
infection and recovery of acetate in C. neoformans-infected tissue call for a study on 
acetate transporter genes that when disrupted, could diminish or sever availability of 
acetate as an alternative carbon source and possibly hinder this pathogen’s survival. 
Acetate transporters’ possible role in facilitating switches to catabolism of secondary 
metabolites essential for fungal survival during starvation could provide a broad anti-
fungal target. This possibility underscores the importance of examining the roles that 
acetate transporters play during C. neoformans infection. 
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Figure 1-1: Pathogenesis of Cryptococcus neoformans. Dessicated cryptococcal cells or 
basidiospores are inhaled. They reach the lungs during which transporters of alternative 
carbon sources such as acetate are upregulated (Mota et al., 2015) and can be contained 
in granuloma or get phagocytosed by alveolar macrophages which is a nutrient poor 
environment (Barelle et al., 2006; Lorenz et al., 2004), at a slightly acidic pH (Vylkova 
and Lorenz., 2014; Cox et al., 2003; Nyberg et al., 1992). When immunity is 
compromised, cryptococci can enter blood circulation and traverse the blood brain barrier 
by A) entry between endothelial cells; B) adhering to being internalized by brain 
microvascular endothelial cells (BMECs); or C) riding in parasitized macrophages 
(PMΦ) (Sabiiti and May, 2012). Blood glucose level is maintained at approximately 0.1 
% (Güemes et al., 2016) and 0.1 % - 0.2 % in the brain (Gruetter et al., 1992) in a slightly 
alkaline pH (O’Meara et al., 2010). This figure was reproduced with minor edits from 
(Sabiiti and May, 2012) with permission from the Future Microbiology journal editor. 
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Figure 1-2: Acetate utilization in Cryptococcus neoformans. In eukaryotic cells, the 
pool of intracellular acetyl-CoA is essential for numerous cellular processes governed by 
histone acetylation and biosynthesis of various metabolic intermediates with energy 
potential. Cytosolic acetyl-CoA is mainly generated from beta-oxidation of fatty acids, 
oxidation of mitochondrial citrate by ATP-citrate lyase (Acl), and activation of acetate by 
AMP-forming acetyl-CoA synthetase (Acs). The C. neoformans acetate transporter, Ady2 
is essential for facilitated uptake of deprotonated or low levels of acetate when present in 
nutrient-limiting condition (Dissertation Chapter 2).  
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Figure 1-3: Acetate production in Cryptococcus neoformans. Metabolic fates of 
acetate in C. neoformans, C. albicans and S. cerevisiae are compartmentalized in the 
cytosol, peroxisome and the mitochondria (Idnurm et al., 2007; Kretschmer et al., 2012). 
Two of these consist of acetate kinase (Ack) partnering with xylulose 5-
phosphate/fructose 6-phosphate phosphoketolase (Xfp) in a modification of the pentose-
phosphate pathway (PPP) to produce acetate from ketose sugars with the formation of 
ATP (Ingram-Smith, et al., 2006). The third uses pyruvate decarboxylase and 
acetaldehyde dehydrogenase to decarboxylate pyruvate to acetaldehyde, which is then 
oxidized to acetate in the presence of NADP+ (Hu et al., 2008).  
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Figure 1-4: Role of acetate transporters in signaling cascade. This model suggests that 
Ady2 plays a role in pH dependent nutrient sensing in response to the acetate signal and 
interacts with the cAMP/PKA pathway responding to cellular levels of acetyl-CoA to 
regulate function of cellular and biosynthetic processes. 
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The success of Cryptococcus neoformans as a pathogen is largely attributable to 
metabolic scavenging during starvation and mounting resistance to antifungals. Lung 
alveolar macrophages, which present a first line of host defense against C. neoformans 
infection provide a glucose- and amino acid-poor environment, and nonpreferred carbon 
sources such as lactate and acetate may be essential during initial pulmonary infection. 
Acetate transporters are required in fungi for the transport and subsequent utilization of 
acetate as a carbon source. While acetate transporters have been characterized in other 
fungi such as Saccharomyces cerevisiae, Candida albicans, Aspergillus nidulans and 
Yarrowia lipolytica, the role of acetate production and transport in C. neoformans is not 
well understood and its importance in infection has not been established. Putative acetate 
transporter genes, designated as ADY2 and ATO2, from the Gpr1/Fun34/YaaH family 
have been identified in C. neoformans and are highly expressed during infection in the 
lung and during growth on acetate as sole carbon source. We propose that Ady2 and Ato2 
have a role in acetate transport as a metabolic adaptation during starvation and stressful 
environmental conditions. Growth of the ady2 mutant and the ady2ato2 double mutant, 
but not the ato2 mutant, was severely impaired when growing on 1 mM versus 10 mM 
acetate plates, suggesting that Ady2 is the essential acetate importer during growth on 
low acetate. Furthermore, ADY2 was induced 137-fold during growth on acetate in 
relation to growth on glucose. The role of Ato2 during prolonged starvation was 
highlighted by diminished acetate uptake by the ato2 mutant after glucose-grown cells 
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were passaged into minimal media with acetate as sole carbon source. This study also 
uncovered a role of Ady2 and Ato2 in ammonia export revealing they preferentially 
import acetate uninhibited by the presence of other carboxylates.  
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Introduction 
Cryptococcus neoformans is an invasive basidiomycetous saprophytic yeast that 
annually infects one million people globally causing over 600,000 deaths (Park et al., 
2009). While it largely co-occurs in sub-Saharan Africa among the immunocompromised, 
especially HIV/AIDs patients whose CD4+ count has dropped below 100 cells/μL (Jarvis 
and Harrison, 2007; Kisenge et al., 2007), C. neoformans var grubii has been documented 
in the US (Pappas et al., 2001) and Asia (Lui et al., 2006) as having higher incidences 
among the immunocompetent than previously estimated. Var. neoformans (serotype A) 
on the other hand has higher incidences in France, Italy and Denmark (Franzot et al., 
1999; Dromer et al., 1996; Tortorano et al., 1997), causing 20-30 % of cryptococcal 
meningitis cases among HIV/AIDs patients. Spores and desiccated yeast cells are C. 
neoformans’ infectious agents. They occur ubiquitously in the environment following 
aerosolization from bird guano, decomposing organic substances, and soil (Sanfelice, 
1894; Velagapudi et al., 2009). Relevant mammalian hosts can inhale aerosolized spores 
or dried yeast cells, developing initial pulmonary infection with a predilection to the brain 
(Sabiiti and May, 2012; Velagapudi et al., 2009). Metabolic adaptability and flexibility 
are important attributes for fungal pathogens to successfully infect and cause disease.  
Although carbon metabolism is critical for virulence in C. neoformans (Price et 
al., 2011), very little is known about which carbon sources are utilized during infection. 
Serial analysis of gene expression study of cryptococcal cells during murine lung 
infection revealed elevated expression of genes involved in acetyl-CoA utilization (Hu et 
al., 2008), implying that acetate is utilized as a carbon source during infection. Among 
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the genes identified were ADY2 (CNAG_05678) and ATO2 (CNAG_05266), encoding 
homologs of Gpr1/Fun34/YaaH family of acetate transporters, and ACS, encoding acetyl-
CoA synthetase that catalyzes the activation of acetate to acetyl-CoA (Hu et al., 2008). A 
C. neoformans acs knockout mutant was unable to utilize acetate, glycerol, and ethanol as
carbon sources but did not have a phenotype with respect to capsule or melanin 
formation, known C. neoformans virulence factors (Hu et al., 2008). However, survival 
of mice infected with this strain was prolonged as compared to the wild type strain, but 
ultimately the mice did succumb to the infection. These findings point to an involvement 
of acetate metabolism during pathogenesis of C. neoformans. However, the role of Ady2 
and Ato2 in C. neoformans metabolism and virulence has not been reported.  
Here, we report the characterization of Ady2 and Ato2 in C neoformans and 
provide experimental evidence of the function of Ady2 as a high affinity, substrate 
specific acetate importer whose expression is induced by acetate. We profile substrate 
requirements of Ady2 and Ato2 to suggest that Ady2 is required for acetate uptake during 
growth on low acetate while Ato2 is required during prolonged starvation in low acetate. 
Ady2 transcript levels are increased ~2.5-fold during fluconazole treatment (Kim et al., 
2015) leading us to hypothesize a possible role of Ady2 and Ato2 in membrane integrity 
and susceptibility to fluconazole. On the other hand, these proteins are not required for 
acetate export, suggesting that there may be another transporter or mechanism to export 
deprotonated acetate out of the cell when necessary. We also rule out roles of acetate 
transporters in membrane integrity or fluconazole susceptibility under the conditions 
tested. 
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Materials and methods 
Cryptococcus neoformans strains 
Individual and double knockouts of ADY2 and ATO2 were kindly provided by the 
Kronstad Lab. Independently created mutants of ADY2 and ATO2 from the Madhani 
collection (Jung et al., 2015) were checked for the same phenotypes as mutants obtained 
from the Kronstad Lab. A cross between the double mutant and the wild type of the 
opposite mating type-KN99a was set up and single mutant strains obtained from this 
cross were confirmed to have lost the distinguishing phenotypic traits of the double 
mutant. In order to achieve this, an equivalent of OD 600 = 2.0 of wild type KN99 
(mating type a) was pelleted and mixed with the same inoculum size of ady2ato2 (mating 
type α), resuspended in 500 μL of sterile nanopure water then spotted onto Murashige 
and Skoog (MS) medium (4.3 g/L Murashige and Skoog basal salt mixture from Sigma-
Aldrich, 1 mL/L of 1000x Murashige and Skoog vitamin solution from Sigma-Aldrich, 
filter sterilized, mixed with 4 % sterile agar and adjusted to pH 5) and left to sporulate in 
the dark for two weeks at ambient temperature. Resulting spores from this cross were 
patched onto YPD containing 100 μg/mL neomycin or nourseothricin. 
To select progeny that had undergone homologous recombination thus regaining 
ADY2 or ATO2 to become single mutant ato2 or ady2 strains respectively, we genotyped 
spores and the parental strains. To do this, we confirmed that the wild type KN99a had 
wild type ADY2 and ATO2 and was susceptible to both neomycin (NeoS) and 
nourseothricin (NatS) and could grow on yeast nitrogen broth (YNB; DifcoTM) 
supplemented with 0.2 % acetate. We also confirmed that mutants lacking ADY2 or 
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ATO2 had instead neomycin resistance (NeoR) or nourseothricin resistance (NatR) and 
thus could grow in the presence of 100 μg/mL of respective antibiotics when included in 
yeast extract peptone dextrose (YPD) media. We also distinguished the NatR ato2 from 
the NeoR ady2 and the ady2ato2 strains due to a requirement of ADY2 during growth on 
YNB supplemented with 0.2% acetate. Similarly, the ato2 mutant strain regenerated from 
this cross replaced the parental strain’s (ady2ato2) NeoR property with a functional ADY2 
as evidenced by a regained ability to grow to wild type levels on YNB supplemented with 
0.2 % acetate while still maintaining its NatR in place of the ATO2 open reading frame 
(ORF). Further to these phenotypes, primers that amplified ADY2 and ATO2 confirmed 
the presence of the ADY2 and the absence of ATO2 ORFs in the newly generated NatR 
ato2; as well as the presence of ATO2 and the absence of ADY2 ORFs in the NeoR ady2 
cross progeny. 
Growth in various carbon sources 
Overnight cultures of individual and double mutants lacking ADY2 and ATO2 
along with their wild type background (H99) were washed twice by pelleting 1 mL of 
culture in the same volume of sterile nanopure water, centrifuged at 3000 x g then 
resuspended in sterile nanopure water at an OD 600 of 0.2. Their cell densities were then 
confirmed by a hemocytometer. These strains were grown in liquid YNB supplemented 
with 10 mM glucose, 60 mM acetate and 6 mM acetate. In addition, four 10-fold serial 
dilutions were spotted in minimal media, YNB agar supplemented with glucose, 
galactose, xylose, lactate, pyruvate, glycerol, ethanol, propionate, butyrate and acetate 
then incubated at 30oC. The plates were incubated observed once every 24 hours. These 
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studies were performed in independent triplicates and data presented as mean ± the 
standard deviation were plotted using JMP® Pro 12.1.0 software and significant P values 
determined by comparing individual mutants to the wildtype H99 using the unpaired t 
test (GraphPad 7, Inc. ).  
Measuring [14C] acetate uptake 
The strains H99, ady2, ato2 and ady2ato2 were grown in liquid YPD cultures to 
an OD 600 of 1.0 at 30oC then washed thrice in sterile nanopure water and resuspended to 
a final concentration of 1x105 cells/μL in 100 μL of sterile nanopure water. Following a 
ten-minute incubation at 37oC, 5 μL of 750 mM, 500 mM, 250 mM and 50 mM of 
unlabeled sodium acetate spiked with labeled sodium acetate (pH 5) in the ratio: 40 mM 
unlabeled sodium acetate to 1mM labeled sodium acetate ([14C] acetate sodium salt 
solution of specific activity 59 mCi/mmol; American Radiolabelled Chemicals) was 
added to the cells homogenously. This reaction was incubated at 37oC for 5 minutes. At 5 
minutes, 1 mL of sterile ice cold nanopure water was immediately added to the cells to 
stop the uptake reaction followed by three washes using cold sterile nanopure water 
through a Vacuum filtration manifold, Millipore® model 1225 through Whatman filter 
papers. These washes alleviated trapping of extracellular [14C] acetate between cells in 
suspension and resolved signal to noise ratio. The filter papers were left to air dry and 
inserted into scintillation vials after which 5 mL of scintillation fluid was added. 
Radioactivity was quantified using a Beckman LS 6000 liquid scintillation counter. 
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Measuring acetate export and media alkalinization 
The strains H99, ady2, ato2 and ady2ato2 were grown overnight in YPD and 
subcultured into YNB supplemented with 2 % glucose, 0.2 % glucose for 20 hours; and 
0.5 % acetate for 20 hours to a cell density of 100,000 cells/μL. At the respective time 
points, 500 μL of the cell suspension was pelleted and 225 μL of the cell lysate was 
collected and used to perform the hydroxamate assay as described by (Aceti and Ferry., 
1988). To generate a standard curve from which to derive concentrations of acetate, the 
assay was first performed on standard concentrations of acetate ranging from 0.1 mM-50 
mM. The hydroxamate reaction mixture used consisting of 0.4 M Tris at pH 7.5, 80 mM 
MgCl2, 2.4 M hydroxylamine, and 90 uM ATP disodum salt hydrate was constituted. Of 
this reaction mixture 75 μL was mixed with 225 μL of the standard solution to the desired 
concentration of acetate, or 225 μL of respective culture supernatant’s filtrate. The 
mixture was agitated thoroughly to ensure mixing after which it was incubated for 5 
minutes at 37oC. Methanosarcina thermophila acetate kinase (Ack) was added to the 
reaction to a concentration of 0.023 ng/μL, homogenously mixed and incubated at 37oC 
for 15 minutes. At the 15-minute time point, the reaction was stopped with a 1:1 ratio of 
20 % trichloroacetate and FeCl3. The absorbance was read at 540 nm by a 
spectrophotometer with a monochromator set at 1 nm bandwidth. 
To detect media alkalinization due to ammonia (NH3) export, growth on GM-BCP 
agar containing glycerol, yeast extract, and the pH indicator bromocresol purple and 
adjusted to pH 3.3 was used to detect media alkalinization. 1 mL cultures of H99, ady2, 
ato2, and ady2ato2 grown overnight at 30oC were collected and washed twice with sterile 
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nanopure water before resuspending in 1 mL of sterile nanopure water to an OD 600 of 
0.2. Homogenous cell density across the strains was then confirmed by hemocytometer. 
Four 10-fold serial dilutions of these cells were spotted onto this GM-BCP agar to 
determine media alkalinization and on YNB supplemented with 100 mM ammonium 
sulfate to investigate a converse role of Ady2 and Ato2 in ammonia export. 
Gene expression of ADY2, ATO2 and ATO3 during growth on acetate versus 
growth on glucose 
We measured the expression of three putative acetate transporters- ATO3 
(CNAG_04787), ADY2 (CNAG_05678) and ATO2 (CNAG_05266) in order to determine 
their induction in response to acetate, relative to the preferred carbon source, glucose. 
The wild type H99 was grown in an overnight YPD starter culture at 30oC after which 
they were washed thrice in sterile nanopure water. Cells were resuspended to an OD 600 
of 0.05 and allowed to grow for 20 hours on YNB supplemented with 0.5 % acetate, and 
YPD. Total RNA was isolated according to the specifications of Aurum™ Total RNA 
Mini Kit (Bio-RadTM). Quantitative RT-PCR (RT-qPCR) was performed according to the 
specifications of the Verso 1-step RT-qPCR SYBR Green ROX kit (ThermoFisher). This 
kit allowed for one step conversion of RNA to cDNA and further cycles to amplify the 
target relative to its abundance using the program: 1 cycle of cDNA synthesis at 50oC for 
15 minutes, 1 cycle of Thermo-Start polymerase activation at 95oC for 15 minutes, then 
40 cycles of denaturation at 95oC for 15 seconds, annealing at 60oC for 30 seconds and 
extension at 72oC for 30 seconds. The reference gene to which relative abundance of 
target gene transcripts was normalized was UBC6 (CNAG_05765) because its expression 
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remained highly stable during more than thirty different metabolic growth conditions 
conditions (Llanos et al., 2015).  
The internal control gene used was actin (ACT1; CNAG_00483) as 18srRNA 
(CNAG_10502) was not utilized after we observed its differential regulation under 
variable conditions (data not shown). Data were analyzed using 2ΔΔCT n to determine 
expression fold change relative to the reference gene as described by Schmittgen TD and 
Livak KJ., 2008. This double delta Ct method compares the number of RT-qPCR cycles 
completed before a fluorescent signal crosses the background noise’s threshold, that is 
the Cycle threshold (Ct) values. Hence the smaller the Ct value, the more abundant the 
target nucleic acid. We used the comparative delta Ct method to contrast 
up/downregulation of ADY2, ATO2 and ATO3, our target genes, relative to UBC6, the 
reference control gene whose expression must not change regardless of experimental 
manipulations. The ACT1 gene, our internal control of relative gene expression, was 
compared against the reference gene, UBC6 as a quality check. Ct values of ADY2, 
ATO2, and ATO3 against UBC6 were presented in the form of fold change of gene 
expression in YNB supplemented with 0.5 % acetate, relative to fold change of gene 
expression in nutrient rich YPD, which contains 2 % glucose.  
Predicting Ady2 and Ato2 membrane topology and examining cell wall and 
membrane stress 
Predictions of the membrane topologies of C. neoformans Ady2 and Ato2 were 
performed by inserting amino acid sequences of Ady2 and Ato2 into the user interface of 
Protter. Using protein topology information, annotation, proteolytic peptides and 
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experimental proteomics data from Uniprot, Phobius, PeptideCutter and such databases 
as PeptideAtlas, consensus structural and feature predictions were performed (Omasits, et 
al., 2013) 
To examine whether loss of Ady2 and Ato2 resulted in increased susceptibility to 
cell wall and membrane stressors, 1 mL cultures of H99, ady2, ato2, and ady2ato2 grown 
overnight at 30 oC were collected and twice washed with sterile nanopure water before 
resuspending the cells in 1 mL of sterile nanopure water to an OD 600 of 0.2. The cell 
density was then confirmed by hemocytometer. Four 10-fold serial dilutions were spotted 
onto YPD plates containing the membrane destabilizing agents, SDS and the cell wall 
stressor, Congo red at a concentration of 1 mg/mL. These plates were incubated at 30oC 
and observed once every 24 hours.  
Investigating susceptibility to fluconazole 
The role of Ady2 and Ato2 during fluconazole treatment was investigated by 
subjecting null mutants and wild type C. neoformans to fluconazole. This was 
accomplished by first growing the H99, ady2, ato2, and the ady2ato2 strains overnight in 
YPD at 30oC. Cell pellets equivalent from these overnight cultures were collected and 
washed twice by centrifugation in sterile water before resuspension to the same volume at 
an OD 600 of 1.0. Using a hemocytometer, 100-fold dilutions of the strains were counted 
to confirm equal cell counts. These strains were inoculated to an OD 600 = 0.2 into liquid 
YNB media supplemented with 0.2 % glucose containing either no fluconazole (control 
environment) or varying concentrations of fluconazole (8 μg/mL, 15 μg/mL, 25 μg/mL 
and 35 μg/mL). Equal cell densities of the strains were ascertained by counting using a 
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hemocytometer. Relative growth inhibition was observed after 16 hours of incubation at 
30oC by comparing the OD 600 values of the different strains in varying concentrations 
of fluconazole against their respective control strain growing in YNB 0.2 % glucose 
lacking any fluconazole. Growth curves of were also performed in YNB supplemented 
with 0.2 % glucose containing 8 μg/mL fluconazole and compared to growth in the 
absence of fluconazole to determine statistical significance by ANOVA (GraphPad 7, 
Inc.).   
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Results 
Role of Ady2 and Ato2 during carbon source utilization following acetate 
uptake 
To examine whether Ady2 or Ato2 influences carbon source utilization, the 
wildtype, ady2, ato2, and ady2ato2 strains were grown on media containing a variety of 
carbon sources. There was no requirement of ADY2 or ATO2 when C. neoformans cells 
were grown on YPD, YNB supplemented with 2 % glucose, 2 % galactose, 2 % acetate, 2 
% glycerol, 2 % ethanol, or 2 % xylose (Figure 2-1a). While both wild type and mutant 
C. neoformans strains displayed robust growth on 10 mM glucose (~0.2 %) (Figure 2-
1b), the cells lacking Ady2 had a slight growth defect on 10 mM acetate but not during 
growth (Figure 2-1b). This phenotype was exaggerated when the acetate concentration 
was dropped 10-fold, such that ady2 mutant did not grow (Figure 2-1b). The ato2 mutant 
did not display any observable growth defect under these conditions. Neither 10 mM 
propionate nor 10 mM butyrate supported growth of C. neoformans wildtype and mutant 
strains while 10 mM pyruvate and 10 mM lactate supported slight growth of C. 
neoformans but there was no requirement for ADY2 or ATO2 (Figure 2-1b).  
Liquid media was able to highlight a contribution of Ato2 in carbon source 
utilization because ato2 cells while they grew to wildtype levels in plate media, their 
growth diminished relative to wildtype in liquid cultures. Although both the wild type 
and mutant strains thrived in 10 mM glucose, loss of Ady2 and Ato2 additively 
diminished growth as demonstrated by the slightly slower growth of the individual 
mutants and even slower growth of the double mutant (Figure 2-2). Similarly, during 
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growth on the relative high acetate concentration of 60 mM (0.5 %) contained in liquid 
YNB cultures, all wild type and mutant C. neoformans thrived but ady2 and ato2 single 
mutants lagged slightly relative to wild type H99. Absence of Ady2 and Ato2 in the 
double mutant led to additively slower growth (Figure 2-3). Upon reducing the acetate 
concentration 10-fold in the liquid YNB cultures, the requirement for Ady2 was further 
pronounced such that both the single mutant lacking Ady2 and the double mutant lacking 
Ady2 and Ato2 had an exaggerated growth defect. Moreover, cells lacking Ato2 had a 
slight defect under these conditions. There was no additive effect from loss of both Ady2 
and Ato2 in the ady2ato2 strain (Figure 2-4).  
For our gene expression studies, we were able to extend our scope of 
investigations to include ATO3 in addition to ADY2 and ATO2 since it is also classified 
under the Gpr1/Fun34/YaaH superfamily of acetate transporters and its role in acetate 
transport has not been characterized. Unlike ADY2 and ATO2, transcripts of ATO3 were 
not elevated during mouse infection (Hu et al., 2008), hence we had not included ato3 
strains in growth studies to characterize ady2 and ato2. To do this, we investigated the 
expression fold change of ADY2, ATO2, and ATO3 in response to the alternative carbon 
source acetate relative to the preferred carbon source glucose. After 20 hours of culture, 
we found expression of ADY2 was highly pronounced in 60 mM acetate relative to 100 
mM glucose (137:1). The expression fold change of ATO2 in 60 mM acetate relative to 
100 mM glucose was slightly increased to the ratio of 1.91:1, while that of ATO3 did not 
change (Figure 2-5). 
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Role of Ady2 and Ato2 in acetate uptake 
To investigate the roles of Ady2 and Ato2 in acetate uptake, we incubated the 
wildtype, ady2, ato2, and ady2ato2 strains with a 40:1 concentration of unlabeled to 
labeled acetate. We found that absence of Ady2 eliminated transport of acetate (Figure 2-
6). The growth defect we observed when ady2 and ady2ato2 strains were growing on 6 
mM acetate also coincided with the requirement of Ady2 for facilitated acetate uptake 
when glucose grown C. neoformans cells were incubated with a 40:1 homogenous 
mixture of unlabeled acetate to labeled acetate at varying concentrations (Figure 2-4, 
Figure 2-6). However, upon growing C. neoformans in acetate for 20 hours and then 
performing the acetate uptake assay, there was a requirement for both Ady2 and Ato2 for 
facilitated uptake of acetate demonstrated by the wild type H99 consistently having 
higher acetate uptake rates (Figure 2-7).  
To examine the substrate specificity of Ady2 and Ato2, we performed 
competition experiments with the carboxylic acids propionate, butyrate, pyruvate, and 
lactate. During these conditions, Ady2 and Ato2 were also specific to acetate import as 
acetate uptake rates were not diminished by substituting unlabeled acetate with 
alternative carbon sources (Figure 2-7). We investigated whether acetate uptake would 
change in the presence of NH3, due to a possible role of acetate transporters in 
acetate::NH3 symport. We found that the presence of NH3 during acetate uptake did not 
alter this pattern either (Figure 2-7). 
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Role of Ady2 and Ato2 in acetate export 
We sought to investigate the roles of Ady2 and Ato2 in acetate export because 
acetate is the most abundant metabolite recovered in culture supernatants during growth 
in glucose (Bubb et al., 1999), and has been identified as the most abundant metabolites 
in brain tissues of infected rats (Himmelreich et al., 2003). When provided with 2 % and 
0.05 % glucose, C. neoformans cells were able to utilize it and produce acetate that was 
detected in the extracellular environment of the culture supernatant after 20 hours of 
culture. However, we observed that loss of Ady2 and Ato2 did not impact acetate export 
when C. neoformans cells were growing in 2 % and 0.05 % glucose as there was no 
significant difference between acetate in the supernatant of the wild type and mutant C. 
neoformans strains (P > 0.05). (Figure 2-8). The hydroxamate assay correlation between 
the concentration of known standards and the assay 540nm absorbance signal between 
the ranges of 0.1 mM-2.0 mM (Figure 2-9a) beyond which the linear relationship was 
lost as the reaction rate slowed with increasing substrate (Figure 2-9b). 
We investigated a possible role of acetate transporters in media alkalinization due 
to a likely excretion of NH3 during culture and saw that Ady2 and Ato2 additively 
contributed to extracellular environment alkalinization by NH3 export but were not 
required for NH3 uptake (Figure 2-9). While the wild type and single mutants of Ady2 
and Ato2 were able to alkalinize GM-BCP (adjusted to pH 3.3) containing glycerol, yeast 
extract, and the pH indicator bromocresol purple, the double mutant lacking both proteins 
was defective in extracellular environment alkalinization. Both Ady2 and Ato2 interacted 
to alkalinize the yellow acidic GM-BCP resulting in a purple hue around the colony 
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where the media had been alkalinized. This defect was not translated to the uptake of 
NH3 as loss of Ady2 and Ato2 did not diminish ability to utilize minimal media 
supplemented with 100 mM ammonium sulfate, they all grew albeit slightly (Figure 2-
10). 
Role of Ady2 and Ato2 in adapting to cell wall and fluconazole antifungal 
stress 
Using the program, Protter (Omasits et al., 2013) C. neoformans Ady2 and Ato2 
were predicted to have six hydrophobic transmembrane proteins, as well as hydrophilic N 
and C termini that are intracellular in Ady2 but extracellular in Ato2. Since C. 
neoformans Ady2 and Ato2 are predicted to span the cryptococcal membrane multiple 
times, (Figure 2-11a and Figure 2-11b), we investigated whether the acetate uptake 
defect in mutants lacking Ady2 was a factor of compromised membrane integrity using 
the membrane perturbing agent SDS and the cell wall stressor, Congo red. We found that 
the loss of Ady2 or Ato2 did not differentially enhance susceptibility to SDS. Liquid 
media supplemented with 10 mM glucose and 1 mg/mL SDS enabled relative comparison 
of susceptibility of the wild type against mutants lacking Ady2 and Ato2. Comparing 
growth of a strain in SDS free media against 1 mg/mL SDS containing media allowed for 
distinguishing the effect of SDS from the growth phenotype due to carbon source 
requirement of the mutant strains. While SDS inhibited growth, the trend was consistent 
with growth rate during growth on 10 mM glucose lacking SDS but not differential 
susceptibility of mutants to SDS (Figure 2-12a). There was no growth defect during plate 
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spot assays of 1 mg/mL Congo red stress despite the cells having assimilated the toxic 
stain to appear as pink colonies (Figure 2-12b, Figure 2-12c). 
To explore a possible link between acetate transport and fluconazole resistance, 
we determined the relative susceptibilities of H99, ady2, ato2 and ady2ato2 in the 
presence of fluconazole. We compared effects of growth over time in YNB containing 
0.2 % glucose and 8 μg/mL fluconazole contrasted to corresponding growth rate in the 
absence of fluconazole (Figure 2-13a).  While 8 μg/mL of fluconazole diminished C. 
neoformans growth, there was no differential susceptibility between the strains (P>0.05). 
We also determined growth differences of H99, ady2, ato2 and ady2ato2 in varying 
fluconazole concentrations compared to corresponding strains lacking fluconazole. Thus 
we revealed an overall susceptibility of C. neoformans to fluconazole but not enhanced or 
diminished by the loss either one or both of Ady2 and Ato2 (Figure 2-13b).  
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Discussion and conclusions 
We hypothesized that Ady2 and Ato2 are essential for facilitated acetate uptake 
during carbon source poor conditions, especially to import charged deprotonated acetate. 
This is because conserved homologs of acetate transporters in other fungi have been 
implicated in acetate transport. An ADY2 homolog in S. cerevisiae was essential for 
permease activity in uptake of acetate and lactate (Pacheco et al., 2012) and was 
upregulated following a switch from glucose-rich medium to a nutrient-poor medium 
supplemented with acetate (Paiva et al., 2004) or during stationary phase after growing in 
nutrient-rich media (Gasch et al., 2000). Our findings indicated that ADY2 was 
selectively essential for growth of C. neoformans on acetate but was not required for 
growth on other carbon sources (Figure 2-1, Figure 2-2).
When acetate was increased to 60 mM in liquid media, the ability of the ady2 and 
ato2 mutants to grow to wild type levels (Figure 2-3) suggests that passive diffusion is 
sufficient in the absence of these transporters. However, the slight growth defect 
experienced by the ato2 mutant strain during growth on minimal liquid media 
supplemented with 6 mM acetate (Figure 2-4) suggests a role for this transporter in very 
low acetate concentration. The severity of the phenotype of relative ability to grow on 
acetate was also reflected in the intensity of upregulation during growth on 60 mM 
acetate for 20 hours such that ADY2 was upregulated dramatically while ATO2 was 
slightly upregulated (Figure 2-5a). The requirement for Ady2 but not Ato2 during initial 
acetate uptake rates following C. neoformans growth on glucose was also confirmed with 
the dramatic upregulation of ADY2 during growth on acetate but not glucose (Figure 2-5, 
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Figure 2-6).  
However, upon passaging C. neoformans from glucose rich YPD (~100 mM 
glucose) into 20 hours of incubation in minimal YNB supplemented with 60 mM acetate 
before radiolabeled acetate uptake assays, a contribution of Ato2 was also demonstrated 
(Figure 2-7). These suggested that Ato2 plays a role in adaptation to prolonged exposure 
to starvation conditions. Effects of these mutations was reminiscent of observations in A. 
nidulans such that upon loss of the acetate permease AcpA, an Ady2 ortholog, there was 
a growth defect on acetate as a sole carbon source especially at higher pH of 6.8 and 8 
when acetate was deprotonated, hence charged and unable to diffuse through the 
membrane (Robellet et al., 2008), suggesting that a transporter would be required for 
utilization of acetate as a sole carbon source at physiological pH of ~7. Moreover, this 
gene was induced by low acetate in S. cerevisiae and cells lacking Ady2 abolished 
saturable, mediated radiolabeled acetate uptake and could only take up acetate by 
diffusion (Paiva et al., 2004). Furthermore, amino acid substitutions in the N-terminus of 
Y. lipolytica Gpr1p induced sensitivity to protonated acetate but deletion of its complete
ORF had no effect, leading to the hypothesis that this protein is involved in adaptation to 
acetate (Gentsch et al., 2007).  
The function of acetate transporters has also been observed in bacteria and 
archaea. Escherichia coli has two acetate transporters that contribute to utilization of 
acetate as a sole carbon source: YaaH, which is specific to acetate and succinate, and 
ActP, a member of the Sodium:Solute Symporter Family (Saier et al., 2006, 
http://www.tcdb.org) that is highly specific for short chain aliphatic monocarboxylates 
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such as acetate, glycolate and propionate (Sá-Pessoa et al., 2013). Deletion of the genes 
encoding both ActP and YaaH was necessary to abolish acetate uptake (Sá-Pessoa et al., 
2013). In Methanosarcina acetivorans, the gene MA4008 was highly expressed during 
growth on acetate versus methanol as a carbon and energy sources along with the genes 
encoding acetate utilizing enzymes, acetate kinase and phosphotransferase (Rohlin and 
Gunsalus, 2010). 
An exploration into the substrate preferences of Ady2 and Ato2 indicated that 
Ady2 was specific for acetate. This is unlike the A. nidulans homolog, AcpA which was 
found to also transport short chain carboxylates albeit with lower efficiency, in addition 
to acetate such that these carboxylates competed with a diminished acetate uptake (Sá-
Pessoa et al., 2015). While Ady2 mutants are severely defective in acetate uptake at low 
concentrations, they were still able to export acetate in conditions in which acetate was 
produced, indicating no apparent role of Ady2 in acetate export (Figure 2-8). Similarly, 
Ato2 was also not required for acetate export. However, the neutral intracellular pH, 
which is above the pKa of acetate, implies that intracellular acetate will exist in its 
deprotonated form and will require a dedicated transporter to export through the 
phospholipid bilayer of the cell wall since passive diffusion of a charged molecule would 
not be possible. Seeing that neither Ady2 nor Ato2 are required for acetate export, we 
hypothesize that yet another protein may be performing this task and efforts are 
underway to characterize Ato3, a third member of the Gpr1/Fun34/YaaH family in C. 
neoformans.  
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Acetate concentrations recovered in the culture supernatants fell between the 
linear range (0.1 mM-2.0mM) of the calibration curve which we used to correlate to 
hydroxamate assay absorbance signal (Figure 2-9a). Beyond 2 mM - 50 mM acetate, the 
linear relationship was lost as the Methanosarcina thermophila Ack became saturated 
resulting in slowed reaction rates (Figure 2-9b). Consistent with the findings of Vylkova 
et al., (2011) in C. albicans, the C. neoformans Ady2 and Ato2 were able to alkalinize the 
extracellular microenvironment from pH 3.3 to a more habitable neutral pH but deletion 
of both proteins caused a defect in pH alkalinization (Figure 2-10). This suggested that 
Ady2 and Ato2 compensate for each other and work in synchronously to alkalinize their 
environment such that a double mutation but not loss of one homolog impacts their pH 
homeostatic function. Efforts are underway to further characterize the mechanisms of this 
function by gene localization and expression. Since mutants lacking Ady2 and Ato2 were 
still able to grow on YNB plates containing 100 mM ammonium sulfate (Figure 2-10), it 
is hypothesized that the threshold at which Ady2 and Ato2 could be required for 
ammonium uptake had not been reached at this concentration.  These observations also 
implied that the cell’s ammonium needs may be adequately fulfilled through uptake of 
complexed ammonia, such as amino acids-which are present in YNB. 
Since these proteins are predicted to span the cryptococcal membrane six times 
(Figure 2-11a and Figure 2-11b), we investigated whether the inability to take up 
acetate by null mutants of Ady2 was a factor of compromised membrane integrity and 
fluconazole resistance. Moreover, acetyl-CoA, a product of acetate metabolizing enzymes 
is a precursor for ergosterol synthesis and Ato homologs in S. cerevisiae were found to 
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localize to detergent resistant membranes enriched in ergosterol (Řičicová et al., 2007), 
the target of fluconazole. However, we found no differential susceptibility of the mutants 
to cell wall stressors (Figure 2-12) suggesting that there is no appreciable membrane 
damage associated to loss of these proteins under the conditions tested. Consequently, 
observed defects in growth may be isolated to the function of these proteins rather than a 
non-specific compromisation of the cell wall through which acetate transport would 
occur.  
We also tested the susceptibility of the mutants when exposed to the cell wall and 
membrane damaging agents Congo red and SDS. The detergent properties of SDS cause 
it to solubilize membrane bilayers while Congo red interacts with cell wall beta-linked 
glucans in vitro and could bind nascent chitin chains causing inhibition of assembly of 
enzymes which polymerize chitin and beta-glucan resulting in a weakened cell wall (Ram 
and Klis et al., 2006). The ubiquitous occurance of fungal beta glucan, chitin and 
membrane lipid bilayers may have resulted in an overall similar effect to the cell walls of 
the H99, ady2, ato2, and ady2ato2 strains. However, it is possible that the cell wall 
ultrastructure may have been differentially affected by loss of Ady2 or Ato2, and detailed 
analysis of cell wall ultrastructure through electron microscopy techniques may reveal 
inapparent cell membrane and cell wall damage.  
Since acetate is a precursor for ergosterol synthesis, an essential target of such 
antifungal azoles as fluconazole, we hypothesized that loss of acetate transporters could 
enhance susceptibility to fluconazole. As conditional and differential gene overexpression 
are believed to highlight an organism’s vulnerabilities when in such dynamic 
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environments as carbon source switches and antimicrobial agents, a potential role of 
Ady2 in fluconazole resistance was highlighted by its approximate 2.5-fold upregulation 
during fluconazole treatment (Kim et al, 2015). Furthermore, Vanden Bossche et al., 
(1992) found that the fluconazole resistant C. glabrata isolate (B57149) had a higher 
[14C] acetate uptake rate and 50 % growth inhibition was not reached after 24 hours of 
incubation with high concentrations of fluconazole (100 μM).  
We therefore hypothesize that during the conditions under which acetate uptake is 
essential, loss of function of Ady2 and Ato2 would enhance susceptibility to fluconazole 
due to diminished ergosterol formation. Nevertheless, under the conditions tested in this 
study of growth curve in 0.2 % glucose supplemented with 8μg/mL fluconazole (Figure 
2-13a), and comparison of differential growth inhibition by 8μg/mL, 15 μg/mL
fluconazole and 35 μg/mL fluconazole (Figure 2-13b), there was no differential 
susceptibility to fluconazole in the wild type versus the mutant strains (Figure 2-13a and 
Figure 2-13b). However, all strains wee uniformly susceptible to all fluconazole 
concentrations, suggesting that Ady2 and Ato2 do not result in enhanced susceptibility to 
fluconazole under the conditions tested. These findings do not however rule out a 
potential role of acetate transport and overall metabolism in fluconazole resistance. 
During growth on glucose, the acetate transporters are not essential, and intracellular 
acetyl-CoA levels may still be enough to support sufficient ergosterol synthesis such that 
differential susceptibility to fluconazole is not apparent. We are further characterizing the 
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Figure 2-1.: Ady2 is required during growth on low acetate. 
a) Plates of YPD, and of YNB supplemented with 2 % glucose, 2 % galactose, 2 %
acetate, 2 % glycerol, 2 % ethanol and 2 % xylose were spotted with serial dilutions of 
H99, ady2, ato2 and ady2ato2 cells. b) Plates of YNB supplemented with 10 mM 
glucose, 10 mM acetate, 1 mM acetate, 10 mM propionate, 10 mM pyruvate and 10 mM 
lactate were spotted with serial dilutions of H99, ady2, ato2 and ady2ato2 cells.  
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Figure 2-2. Ady2 and Ato2 additively contribute to growth in 10mM (~0.2 %) 
glucose. Overnight cultures of H99 , ady2 , ato2 , and ady2ato2 
that had been grown in YPD at 30oC were subcultured into liquid YNB supplemented 
with 10 mM glucose (~0.2 %) at an OD 600 of 0.2 then growth was followed for up to 48 
hours. Error bars indicate standard deviation from the mean of triplicate values.  
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Figure 2-3. Ady2 and Ato2 additively contribute to growth in 60 mM acetate. 
Overnight cultures of H99 , ady2 , ato2 , and ady2ato2   that had 
been grown in YPD at 30oC were subcultured into liquid YNB supplemented with 60 
mM acetate (0.5 %) at an OD 600 of 0.2 then growth was followed for up to 48 hours. 
Error bars indicate standard deviation from the mean of triplicate values. 
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Figure 2-4. Ady2 is required while Ato2 contributes to growth in 6 mM acetate. 
Overnight cultures of H99 , ady2 , ato2 , and ady2ato2  that had 
been grown in YPD at 30oC were subcultured into liquid YNB supplemented with 6 mM 
acetate (0.05 %) at an OD 600 of 0.2 then growth was followed for up to 48 hours. Error 
bars indicate standard deviation from the mean of triplicate values. 
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Figure 2-5. ADY2 is induced during growth on acetate relative to glucose. a) 
Expression fold change of ADY2, ATO2 and ATO3 during growth on 60 mM acetate for 
20 hours: After 20 hours of culture, expression of ADY2 and ATO2 in 100 mM glucose-
grown C. neoformans cells was compared against that of 60 mM acetate-grown cells. 
Fold changes were represented as Log2 values such that on average ADY2 expression 
increased 137-fold (27.17) while ATO2 increased 1.91-fold (20.94). Error bars indicate 
standard deviation from the mean of triplicate expression fold change values. 
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Figure 2-6. Ady2 is essential for facilitated acetate uptake after growing cells in 
glucose. C. neoformans cell suspensions of H99 , ady2 , ato2 , and 
ady2ato2  were grown in YPD to an  OD 600 of 1.0 (~100,000 cells/μL) then washed 
and incubated for 5 minutes in a 40:1 mixture of unlabeled acetate to labeled acetate and 
intracellular [14C] acetate was measured by a scintillation spectrophotometer. The rate of 
uptake per cell was plotted against μM acetate. Error bars indicate standard deviation 
from the mean of triplicate values. 
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Figure 2-7. After prolonged starvation Ato2, like Ady2 is required for acetate 
uptake and they are specific for acetate in the presence of other carbon sources. 
Glucose grown C. neoformans were washed and transferred into 0.5 % acetate for 20 
hours then incubated with a 40:1 ratio of unlabeled acetate, equimolar NH3 and acetate 
mixture, butyrate, propionate, lactate and pyruvate (250 μM) to [14C] acetate (6 nM). 
Error bars indicate standard deviation from the mean of triplicate values. 
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Figure 2-8. Loss of Ady2 and Ato2 does not affect acetate export. Levels of 
extracellular acetate in the culture supernatant were measured by hydroxamate assay. 75 
μL of hydroxamate reaction mixture (0.4 M Tris at pH 7.5, 80 mM MgCl2, 2.4 M 
hydroxylamine, and 90 μM ATP disodum salt hydrate) was mixed with 225 μL of the 
culture supernatant. The mixture was agitated thoroughly then incubated for 5 minutes at 
37oC. Methanosarcina thermophila acetate kinase (Ack) was added to the reaction to a 
concentration of 0.023 ng/μL, homogenously mixed and incubated at 37oC for 15 
minutes. At the 15-minute time point, the reaction was stopped with a 20 % 
trichloroacetate and FeCl3 in 10 N HCl in 1:1 ratio and OD 540 was measured. Error bars 




Figure 2-9. Hydroxamate assay signal has linear correlation to acetate concentration 
between 0.1 mM - 2 mM. To demonstrate sensitivity of the hydroxamate assay we used 
to detect levels of extracellular we generated a standard curve by performing the assay 
with known acetate concentrations. a) Linear relationship between acetate concentration 
ranging from 0.1 mM-2.0 mM and the hydroxamate assay signal b) Beyond 2 mM-50 
mM acetate concentrations the linear relationship between acetate concentration and 
hydroxamate assay signal is lost. Error bars indicate standard deviation from the mean of 
triplicate values. 
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YPD  GM BCP           ammonium sulfate 
Figure 2-10. Ady2 and Ato2 additively contribute to extracellular environment 
alkalinization by NH3 export. Glucose grown C. neoformans were washed and serial 
dilutions were spotted onto a standard YPD plate to provide optimum growth conditions. 
The medium GM-BCP containing glycerol, yeast extract, and the pH indicator 
bromocresol purple and adjusted to pH 3.3 was used to detect media alkalinization due to 
NH3 export. YNB agar supplemented with 100 mM ammonium sulfate was used to 









Figure 2-11. a) Predicted membrane topology of Cryptococcus neoformans Ady2. 
Using the program Protter, Cryptococcus neoformans Ady2 probable membrane topology 
was visualized. Ady2 N and C termini are speculated as being intracellularly localized. b) 
Predicted membrane topology of Cryptococcus neoformans Ato2. Cryptococcus 
neoformans Ato2 probable membrane topology was visualized using Protter. Ato2 N and 
C termini are speculated as being extracellularly localized. Residues that are circled align 
to Y. lipolytica Gpr1p that when mutated result in sensitivity to acetate (Gentsch et al., 
2007)-blue indicates predicted intra-membrane location of the residues while orange 
indicates extracellular residue location.   
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   SDS stress    1mg/mL Congo red 
Figure 2-12: Loss of Ady2 and Ato2 does not compromise cell wall integrity during 
20 hours of 1 mg/mL SDS stress (P>0.05 unpaired t test, GraphPad 7, Inc.) or 
Congo red stress. a) H99, ady2, ato2 and ady2ato2 were grown in YNB containing 10 
mM glucose and 1 mg/mL SDS and 1 mg/mL Congo red. As a control, the same 
experiment was replicated without SDS. While growth was inhibited by SDS, the trend 
was consistent with growth rate during growth on 10 mM glucose lacking SDS, thus 
uncoupling the effect of SDS from the growth phenotype due to carbon source 
requirement of the mutant strains. Error bars were created from standard deviation from 
the mean of triplicate values. b) There was no growth defect during Congo red stress and 




Figure 2-13: Loss of Ady2 and Ato2 does not impact fluconazole susceptibility 
(P>0.05, unpaired t test, GraphPad 7, Inc. ). a) Growth curves of H99, ady2, ato2 and 
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ady2ato2 were grown in YNB containing 0.2 % glucose and 8 μg/mL fluconazole ( ) 
and compared to corresponding growth rate in the absence of fluconazole ( ). b) H99, 
ady2, ato2 and ady2ato2 were grown in YNB containing 0.2 % glucose and 8 μg/mL, 15 
μg/mL and 35 μg/ml fluconazole at 30oC for 16 hours. As a control, the same experiment 
was replicated without fluconazole. Error bars indicate standard deviations from the mean 
of absorbance at OD 600nm values. 
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Cryptococcus neoformans, the leading cause of fungal meningitis resulting in 
over 600,000 annual deaths, has adapted to survive in its mammalian host environment. 
Carbon metabolism is critical for virulence in C. neoformans and nonpreferred carbon 
sources such as acetate are likely essential energy sources during initial pulmonary 
colonization. We investigated the roles of two acetate transporters, Ady2 and Ato2, in the 
virulence of C. neoformans. Deletion of Ady2 and Ato2 led to a defect in growth at 37oC, 
impaired capsule formation, led to higher susceptibility to phagocyte-mediated clearance, 
and instigated cell-cell aggregation phenotype resulting in flocculation during starvation 
conditions, and a diminished ability to modulate environmental pH while facilitating 
acetate uptake under starvation conditions. Moreover, high inducement of ADY2 and 
ATO2 during growth on glucose rich media versus nutrient limiting media suggested an 
involvement of Ady2 not only in acetate import but in overall adaptation to nutrient poor 
conditions at high pH. Loss of Ady2 and Ato2 caused diverse metabolic and cellular 
defects that together led to high attenuation of virulence, a complex phenotype governed 
by various adaptive properties of C. neoformans. These diverse phenotypes from loss of 
Ady2 and Ato2 suggest that acetate transport may be linked to homeostasis of 
intracellular acetyl-CoA pool, a central carbon metabolite essential for biosynthetic and 
cellular processes. Thus, the loss of Ady2 and Ato2 has far reaching effects: affecting 
crosstalk between effectors of the master-regulation of metabolism such as the cAMP-
PKA signaling cascade, inhibiting alternative catabolic pathways during energy 
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limitation, and inhibiting protein, carbohydrate, lipid biosynthesis, cell growth and 
proliferation.    
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Introduction 
From the approximately 1,000,000 annual incidences of the basidiomycetous 
Cryptococcus neoformans infections globally, over 600,000 yearly deaths result, the bulk 
of which are in Sub-Saharan Africa (Sloan and Parris, 2014). Following an initial 
pulmonary infection, cryptococcal cells encounter a nutrient deprived environment within 
the lungs as the invading cells are taken up by resident alveolar macrophages which are 
the first immune cells to interact with invading C. neoformans (Diamond et al., 1974). 
During murine pulmonary infection, the glyoxylate pathway, fatty acid beta-oxidation, 
gluconeogenesis, and amino acid synthesis are induced in C. neoformans suggesting 
metabolic adaptation to a nutrient limited environment (Hu et al., 2008).  Moreover, 
acetate was the most abundant metabolite recovered from the lungs of infected Female 
Fisher rats (Himmelreich et al., 2003) consistent with the elevated transcript levels of 
proteins involved in acetate transport and metabolism. Specifically, acetyl-CoA 
synthetase (Acs) which catalyzes acetate activation to acetyl-CoA, and pyruvate 
decarboxylase, aldehyde dehydrogenase, xylulose 5-phosphate/fructose 6-phosphate 
phosphoketolase which catalyze acetate production, as well as two putative acetate 
transporters were induced during murine pulmonary infection (Hu et al., 2008; Kronstad 
et al., 2012). Furthermore, an acs mutant was attenuated in virulence and could not utilize 
acetate as the sole carbon source (Hu et al., 2008).   
An immunocompetent host can effectively combat an initial C. neoformans 
pulmonary infection thus clearing it through Th1-like responses induced by classically 
activated macrophages rather than the ineffective alternatively activated Th2 responses 
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(Rohatgi and Pirofski et al., 2015). Neutrophils contain C. neoformans in the lungs within 
a granuloma then kill them oxidatively, non-oxidatively or with the aid of antimicrobial 
peptides (Rohatgi and Pirofski et al., 2015). In blood circulation, neutrophils have 
effective non-specific anticryptococcal response. However, in an immunocompromised 
host, the internalization of C. neoformans by activated macrophages can be 
counterproductive because the cryptococcal cells adapt to this environment and 
proliferate within macrophages. Phagocytosed cells can then non-lytically exit 
macrophages into the bloodstream or remain inside parasitized macrophages that traverse 
into blood circulation. While the intracellular environment within tissue resident 
phagocytes and in the lung mimics culture conditions in minimal media lacking preferred 
carbon sources, blood has elevated glucose which is maintained at an average of ~7.5 
mM according to a rat model (Dunn-Meynell et al., 2009).  
C. neoformans is uniquely adapted to its in vitro and in vivo environment, as it
tightly regulates environmental pH, senses nutrients, adjusts metabolism, and actively 
evades the host’s antifungal immune attempts. We have previously identified two 
transporters, designated as ADY2 (CNAG_05678) and ATO2 (CNAG_05266), from the 
Gpr1/Fun34/YaaH family of acetate transporters as being essential for modulating 
extracellular and intracellular environments thus heavily impacting pathogen survival in 
the environment and the host. During starvation in minimal media supplemented with 
acetate, ADY2 is dramatically upregulated and both ADY2 and ATO2 are required for 
acetate uptake as a carbon source (Dissertation Chapter 2). Acetate taken up can be 
subsequently activated by Acs to acetyl-CoA to enter the central carbon metabolism after 
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depletion of preferred carbon sources such as glucose, whose metabolism results in 
carboxylic acid intermediates.  
During infection, C. neoformans encounters a variety of host environmental 
niches that drastically vary pH and whose accumulation could be toxic to cells. 
Consistent with C. neoformans’ metabolic versatility that makes it saprophytic, ammonia 
extrusion following gluconeogenic catabolism of NH3 compounds could alkalinize 
environments to selectively high pH levels. This phenomenon is demonstrated during 
necrotropic colonization of dead plant tissue by fungi Colletotrichum acutatum and 
during invasion by commensal pathogen Candida albicans. This ability to raise 
environmental pH autoinduces hyphal morphogenesis, one of C. albicans’ virulence 
factors (Vylkova et al., 2011) that leads to invasive host colonization. Pathogens’ ability 
to sense and actively modulate their environments enhance their remarkable ability to 
prevail despite host attempts to expel them by creating harsh microenvironments. Media 
alkalinization by C. albicans was limited by presence of glucose, hence hypothesized to 
be glucose repressible (Vylkova et al., 2011). This observation suggests that pH is 
modulated in a carbon source dependent manner. 
This study seeks to evaluate the roles played by Ady2 and Ato2 in C. neoformans 
virulence given their drastic contributions to the pathogen’s propensity to adapt to 
unfavourable environments. Cells lacking Ady2 and Ato2 are unable to grow at human 
body temperature of 37°C, are diminished in capsule formation, and are generally 
impaired in their ability to cause mortality in mice. These diverse effects in addition to 
our previous studies on roles of Ady2 and Ato2 in metabolic adaptation (Dissertation 
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Chapter 2) suggest crosstalk between acetate transport, the resulting impact on 
intracellular acetyl-CoA pool and master-regulator of metabolism, stress responses and 
epigenetic regulation of cellular processes (possibly through the SNF/PKA signaling 
cascade). 
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Materials and methods 
Strains and morphological characterization 
The C. neoformans ady2, ato2, and ady2ato2 knockout strains were kindly 
provided by Dr. James Kronstad (Michael Smith Laboratories, University of British 
Columbia, Vancouver, Canada).  Independently created mutants of Ady2 and Ato2 from 
the Madhani collection (Jung et al., 2015) were checked as having similar phenotypes as 
mutants obtained from the Kronstad Lab. Strains were grown in the minimal medium, 
YNB (DifcoTM) supplemented with 0.2 % glucose at 30oC with moderate aeration.  
Flocculation was observed by cell-cell aggregation as C. neoformans cultures 
were grown to mid-log phase then resuspending them by vortexing and allowing them to 
settle such that the most flocculent strains would settle to the bottom of the culture tube 
faster. Fluorescent and light microscopy using an Axiovert® inverted microscope was 
then performed to examine C. neoformans cell-cell aggregation in relation to 
flocculation. To do this, a drop of Calcofluor White Stain (Sigma-Aldrich) was mixed 
with the C. neoformans strains and one drop of 10 % KOH on a slide after which a 
coverslip was placed over the sample and the set-up was incubated for 1 minute at 
ambient temperature followed by observing under the DAPI filter of the Axiovert® 
inverted microscope x40 magnification in comparison to the visible light filter. 
To regenerate the single mutants for replication of phenotypes of individual null 
mutants, the Ady2 and Ato2 single mutants were crossed with KN99a and allowed to 
sporulate on Murashige and Skoog media (4.3 g/L Murashige and Skoog basal salt 
mixture from Sigma-Aldrich, 1mL/L of 1000x Murashige and Skoog vitamin solution 
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from Sigma-Aldrich, filter sterilized, mixed with 4 % sterile agar and adjusted to pH 5) at 
ambient temperature in the dark. Individual spores were obtained and allowed to 
germinate on YPD (DifcoTM) containing the respective selection antibiotics after which 
the strains were genotyped by PCR to confirm presence of the intended single gene and 
absence of its counterpart.  
Examining virulence factors in C. neoformans 
Capsule formation was induced by first washing overnight YPD cultures of H99, 
ady2, ato2 and ady2ato2 strains with sterile nanopure water then introducing 10,000 of 
these cells into a 2 mL culture of CO2-independent media (GibcoTM). This culture was 
then left to grow with aeration by shaking at 37oC. A dense cell suspension was stained in 
India ink (VWR®) at a 1:1 ratio and the capsule formation discerned from the resistance 
of the capsule to India ink staining such that a halo occurred around encapsulated cells 
when observed by light microscopy. Colony morphology of encapsulated versus the 
unencapsulated cells was observed during growth of C. neoformans in capsule inducing 
plate media (CO2-independent media for mammalian cell culture containing 2 % agar).  
The ability to produce melanin and to grow at mammalian body temperature of 
37oC was investigated by first growing overnight cultures of individual and double 
mutants lacking ADY2 and ATO2 along with their wild type background (H99). These C. 
neoformans strains were then washed twice by pelleting 1 mL of culture in the same 
volume of sterile nanopure water, centrifuging at 3000 x g then resuspended in sterile 
nanopure water at an optical density (OD) 600 of 0.2. Their cell densities were confirmed 
to be equal by hemocytometer counting. For the melanin production analyses, four 10-
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fold serial dilutions of these strains were spotted onto minimal media, YNB 2 % agar 
supplemented with 1 g/L glucose, 1 g/L L-asparagine, 3g/L KH2PO4, 250 mg/L MgSO4, 
100 mg/L L-DOPA, 1 mg/L Thiamine HCl, adjusted to pH 5.6 and left to grow in the 
dark at 30oC. Melanin production was also investigated with a higher C. neoformans cell 
density starting serial dilutions with 2 x 106 cells and subsequent 100-fold dilutions to 
investigate the roles of cell density and growth rate on melanin production.  
For the experiments to investigate H99, ady2, ato2 and ady2ato2 mutants' 
thermotolerance at mammalian body temperature, overnight C. neoformans cultures were 
washed twice by pelleting 1 mL of culture in the same volume of sterile nanopure water, 
centrifuging at 3000 x g then resuspended in sterile nanopure water at an OD 600 of 0.2. 
After confirming equal cell density between the strains by checking their absorbance at 
600 nm and counting them using a hemocytometer, four 10-fold serial dilutions of were 
spotted onto minimal media, YNB 2 % agar supplemented with 0.2 % glucose and on 
YPD plates containing 2 % agar then incubated at 37oC. 
Fungal killing by human neutrophils 
C. neoformans cultures were first grown overnight in YPD cultures then washed
thrice by pelleting at 300 x g for 5 minutes then resuspending in 1 mL PBS buffered at 
pH 7.4 (GibcoTM) and diluting to 1,000 cells/uL. Venipuncture was performed on healthy 
blood donors to obtain peripheral blood of which 10 mL was coagulated to yield serum 
while another 10 mL was anticoagulated using 10 U of pyrogen-free heparin (Elkins-
Sinn, Inc., Cherry Hill, N.J.) per mL. Holding the Falcon tube (Becton Dickinson)
containing uncoagulated blood tipped at a slight angle, 5 mL of Mono Poly resolving 
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medium was dispensed in a slow steady stream over the medium’s interface to avoid 
mixing. The VacutainerTM (Becton Dickinson) containing coagulated blood and the 
falcon tube containing uncoagulated blood were centrifuged at 300 x g for 15 minutes at 
ambient temperature without breaks.  
Serum was obtained from the VacutainerTM while neutrophils were obtained from 
the second-densest fraction of the density-separated blood. The obtained neutrophils were 
resuspended in RPMI 1640 medium (Gibco™) which had been prewarmed at 37oC. The 
neutrophil suspension was then pelleted by centrifuging at 300 x g at ambient 
temperature.  Contaminating red blood cells were lysed using 500 μL of 1x Red Blood 
Cell Lysis Buffer (Roche). The resulting neutrophils were resuspended to a density of 
1000 neutrophils/μL in RPMI 1640 medium prewarmed at 37oC. A coculture of 80,000 
neutrophils and 10,000 C. neoformans cells was rotated for 2 hours at 37oC and then 
pelleted by centrifugation at 300 x g for 5 minutes. Neutrophils were lysed osmotically 
by incubating them in 1mL of sterile nanopure water for 10 minutes followed by 
vortexing. Triplicates of 100x dilutions were done to determine % surviving C. 
neoformans = (untreated CFU/treated CFU) x 100.
Fungal killing by mouse derived J774.16 cell line 
Overnight C. neoformans cultures were grown in YPD cultures then washed 
thrice by pelleting at 300 x g for 5 minutes then resuspended in 1 mL PBS buffered at pH 
7.4 (GibcoTM) and diluting it to 1,000 cells/μL. The J774.16 mouse macrophage cell line 
was passaged weekly in 10 mL Dulbecco’s Modified Eagle Medium (DMEM; Gibco™ 
Life Technologies) supplemented with 10 % heat-inactivated fetal calf serum, 1 % non-
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essential amino acids, 100 μg/mL penicillin-streptomycin, and 10 % NCTC-109 medium 
(all from Gibco™ Life Technologies). A coculture of 80,000 macrophages activated with 
10 nM phorbol myristate acetate (PMA) and 10,000 C. neoformans cells opsonized with 
1 μg/mL mAB18B7 (kindly provided by Dr. Arturo Casadevall, Johns Hopkins 
Bloomberg School of Public Health) was rotated for 2 hours at 37oC then was pelleted by 
centrifuging at 300 x g for 5 minutes. For the 24-hour phagocytosis assay, un-engulfed C. 
neoformans were gently aspirated from the coculture after 1 hour of co-incubation. 
Macrophages were lysed osmotically by incubating them in 1 mL of sterile nanopure 
water for 10 minutes followed by vortexing. Triplicates of 100x dilutions were spotted 
onto YPD plates for quantification and survival was determined by the equation:  % 
surviving C. neoformans = (untreated CFU/treated CFU) x 100. 
Investigating virulence of C. neoformans in the C57BL/6 mouse model  
To investigate the roles of Ady2 and Ato2 in virulence during infection of the 
vertebrate mouse model, Cryptococcus neoformans strains H99, ady2, ato2 and ady2ato2 
were cultured overnight in 3 mL of YPD then diluted to 2x105 cells/mL in PBS buffered 
at pH 7.4 (GibcoTM). C57BL/6 mice 6-7 weeks old received an oral tracheal infection of 
10,000 C. neoformans strains in two biological replicates with five mice per strain. The 
oral tracheal infection was delivered using a finely tipped pipette inserted into the mouth 
of temporarily anaesthetized mice such that 50 uL of C. neoformans cell suspension was 
aspirated down the trachea.  
Biological replicates were started on separate days and used two independent 
C57BL/6 mouse batches (Jackson Laboratories, Bar Harbor ME and Charles River 
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Laboratories, Wilmington, MA). Mortality was determined by observing mice every 24 
hours and sacrificing moribund ones. To determine fungal load in the surviving mice the 
murine lungs were harvested, weighed and suspended in 4 mL of PBS buffered at pH 7.4 
(GibcoTM) containing 200 U/mL of Penicillin-Streptomycin solution supplied in 100x 
formulation (GibcoTM). The lung tissue in PBS buffered at pH 7.4 was then mechanically 
ground using a tissue homogenizer (Miltenyi Biotec). Colony forming units (CFU) were 
determined by spotting homogenate suspension on Saboraud Dextrose Agar at pH 5.6 
(Thermo ScientificTM) and counting the resulting colonies. Kaplan Meier survival 
analysis graphs were generated using GraphPad Prism 5. 
Examining the roles of Ady2 and Ato2 in pH modulation of media 
C. neoformans strains were grown overnight in YPD at 30°C then pelleted by
centrifugation and washed 3x using sterile nanopure water. The cells were resuspended to 
an OD 600 of 0.05 in YPD, YNB supplemented with 0.5 % acetate, and GM-BCP media 
containing glycerol, yeast extract, and the pH indicator bromocresol purple adjusted to 
acidic or alkaline pH using HCl or NaOH and grown at 30°C with aeration. pH indicator 
colour changes in cultures were monitored every 24 hours. A pH sensitive stain, 
pHrodo® (ThermoFisher, Inc.) was used to stain and image cells. To do this, dense cell 
suspensions were washed by centrifuging at 300 x g in PBS buffered at pH 7.4 then 
incubated with 5 µM pHrodo™ Red AM Intracellular pH Indicators in PowerLoad™ 
(ThermoFisher, Inc.) for 30 minutes at ambient temperature, then 30 minutes at 37°C to 
provide an indication of intracellular pH in live cells during culture. This preparation was
then visualized under the rhodamine filter of the Axiovert® inverted microscope. 
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After twenty hours, total RNA was isolated as previously described (Dissertation 
Chapter 2) and according to the specifications of Aurum™ Total RNA Mini Kit (Bio-
RadTM). Quantitative RT-PCR was performed using the Verso 1-step RT- qPCR SYBR 
Green ROX kit (ThermoFisher Inc.). Data was normalized to UBC6 because of its highly 
stable expression (Llanos et al., 2015). Using the double delta Ct (cycle threshold) 
method (2ΔΔCt) method described by Schmittgen TD and Livak KJ., (2008), the 
expression fold change of ADY2, ATO2 and ATO3 relative to the reference gene was 
determined. This double delta Ct method used comparative Ct (Cycle threshold) values, 
which indicated the number of RT-qPCR cycles completed before a fluorescent signal 
crossed the background noise’s threshold. Hence the less the Ct value, the higher the 
abundance of the target nucleic acid.  
Our comparative delta Ct method contrasted the target genes under experimental 
manipulations, ADY2, ATO2 and ATO3 relative to UBC6 (CNAG_05765) the reference 
control gene whose expression must not change regardless of experimental manipulations 
(Llanos et al., 2015). Target gene Ct values were compared relative to the internal control 
UBC6 such that values of target genes below those of UBC6 indicated relatively reduced 
transcript levels while values of target genes above this defined threshold indicated that 
transcript levels were elevated. We also used an internal control encoded by the ACT1, 
which was compared against UBC6 as a quality check as it is typically constitutively 
expressed despite experimental manipulations. To obtain fold change of gene expression 
in nutrient limited YNB relative to the nutrient rich YPD, which contains 2 % glucose, 
the Ct values of ADY2, ATO2, and ATO3 against UBC6 were compared within the growth 
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conditions and values presented in the form of fold change of gene expression in YNB 
supplemented with 0.5 % acetate, relative to fold change of gene expression in YPD. 
The ability to modulate pH and survive at physiologically relevant pH of 4.5 and 
7 was investigated by first growing overnight cultures of individual and double mutants 
lacking ADY2 and ATO2 along with the wild type H99. These C. neoformans strains were 
then washed twice by pelleting 1 mL of culture in the same volume of sterile nanopure 
water, centrifuging at 3000 x g then resuspended in sterile nanopure water at an OD 600 
of 0.2. Their cell densities were confirmed to be equal by hemocytometer counting after 
which 2 μL of four 10-fold serial dilutions of H99, ady2, ato2 and ady2ato2 were spotted 
onto minimal media, YNB agar supplemented with 0.5 % acetate and adjusted to pH 4.5 
and 7.0 then incubated at 30oC. 
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Results 
       To assess the roles played by Ady2 and Ato2 in maintaining intact C. neoformans 
cell morphology, we evaluated the cells and culture suspensions of wild type H99 versus 
the mutant strains ady2, ato2 and ady2ato2 and found that ady2ato2 was impacted by the 
loss of Ady2 and Ato2 at 30oC in YNB supplemented with 0.2 % glucose. Unlike the 
wild type C. neoformans and the ady2 and ato2 strains which were in a dispersed single-
celled monolayer, the ady2ato2 strain clumped to develop strings of unseparated cells 
(Figure 3-1a). In addition to clumping at the microscopic level, the double mutant cells 
were flocculent as they clumped macroscopically such that their liquid cultures settled 
faster than their single mutant or wild type strains (Figure 3-1b). 
  We next investigated the contributions of Ady2 and Ato2 towards ability to 
remain viable and grow at mammalian body temperature, polysaccharide capsule as well 
as synthesis of melanin, the three major virulence determinants of C. neoformans. While 
ady2 and ato2 retained wild type levels of thermotolerance, the ady2ato2 strain had a 
heightened thermosensitivity such that its growth was impaired at 37oC (Figure 3-2). 
Moreover, loss of both Ady2 and Ato2 impacted capsule production. While the wild type 
and single mutant strains formed a capsule and hence were resistant to negative staining 
by India ink, leaving a halo around their encapsulated cells, the double mutant was 
impaired in capsule formation (Figure 3-3a). During these capsule-inducing conditions 
on agar, the unencapsulated strains formed textured colonies devoid of the glossy sheen 
morphology observed on the strains that still had capsule (Figure 3-3b). While 
melanization occurred in the single ady2 and ato2 mutants, the loss of both Ady2 and 
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Ato2 caused a defect in melanin production when a cell density starting from 104 cells 
was spotted on media containing dopamine (Figure 3-4a). However, increased cell 
density to start at 2x106 resulted in melanization of all four strains (Figure 3-4b). 
 We investigated whether the presence of acetate transporters (which enable 
adaptation to the low pH that is characteristic of acetate) would also confer a survival 
advantage to C. neoformans killing by phagocytes, whose predominant environment is 
slightly acidic. Macrophages are the first resident immune effectors to contact and 
phagocytose invading cells then link host innate oxidative mediated killing, and adaptive 
antifungal mechanisms (Rohatgi and Pirofski et al., 2015). However, macrophages can be 
parasitized and support cryptococcal proliferation (Diamond and Bennet, 1973). We 
observed that neither individual nor double mutants of Ady2 and Ato2 were differentially 
killed by mouse macrophage-like cell lines during a 2 hour coculture (Figure 3-5). 
However, after the 24-hour phagocytosis assay, ato2 and ady2ato2 but not ady2 were 
susceptible to macrophage antifungal activity (Figure 3-5).  
We also looked into the roles played by Ady2 and Ato2 during C. neoformans 
killing by neutrophils, which contain C. neoformans infection within a granuloma in the 
lungs.  Neutrophils in blood also phagocytose C. neoformans. They execute 
anticryptococcal action oxidatively, non-oxidatively or with the aid of antimicrobial 
peptides (Rohatgi and Pirofski et al., 2015). Neutrophils are effective in cryptococcal 
clearance even in the absence of C. neoformans opsonization (Miller and Mitchell, 1999). 
Unlike macrophages, human neutrophils were able to kill the double ady2ato2 mutant 
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significantly more efficiently than the wild type (P=0.0045, GraphPad Prism 7, Inc. 
unpaired t-test) or the single mutants (P>0.5) after a 2 hour coculture (Figure 3-5).  
Our cumulative virulence-associated observations of mutants lacking Ady2 and 
Ato2 being defective in major virulence determinants of C. neoformans in addition to 
preferential killing of ady2ato2 by neutrophils led us to investigate the virulence roles of 
Ady2 and Ato2 in a mouse (C57BL/6) model. Not surprisingly, the double ady2ato2 
mutant was highly attenuated in virulence such that the mouse group infected with this 
strain continued to survive and did not succumb to infection despite the groups infected 
with H99, ady2 and ato2 having died from infection approximately 15 days earlier 
(Figure 3-6). However, upon sacrificing the surviving mice after 50 days of the 
experiment, the fungal load was maintained at an average of the original inoculum of 
10,000 C. neoformans (Figure 3-6).  
We investigated the possibility that Ady2 and Ato2 have a role in environmental 
adaptation to physiologically relevant environment that C. neoformans encounters and 
must adapt to during infection. To do this we observed relative growth rates of H99, 
ady2, ato2 and ady2ato2 as well as gene expression of acetate transporters during nutrient 
deprived environments at slightly acidic (macrophage-like) and slightly alkaline 
conditions (similar to human blood and brain environments) against the basis of nutrient 
rich YPD. We uncovered a role of Ady2 and Ato2 in modulating C. neoformans 
environmental pH such that the cells actively acidified the extracellular environment in a 
nutrient-dependent manner as seen by 20 hour and 72 hour C. neoformans cultures 
maintaining a yellow colouration characteristic of acidic pH as illustrated on the cell free 
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panel (Figure 3-7). Moreover, we observed yellowing of the area surrounding the 
colonies growing on nutrient rich YPD agar (Figure 3-7). Figure 3-8a shows H99, ady2, 
ato2, and ady2ato2 after 20 hours and 72 hours of growth as they alkalinize acidic GM-
BCP. The cell free panel indicates the colour calibration of media at varying pH. This 
progression of media alkalninization is also shown on plate cultures as the colonies turn 
colour between day 2-6 before alkalinizing the media. The ady2ato2 strain alkalinized the 
media relariveley slower than other strains.  
When stained with the cytosolic pH stain, pHRodo, cells from the 5-day spot 
fluoresced (Figure 3-8b). After 48 hours of growing in test tube cultures, ady2 and 
ady2ato2 strains were slower than H99 and ato2 strains in media alkalinization (Figure 
3-8c) while by 60 hours, H99, ady2, ato2 but not ady2ato2 had alkalinized GM-BCP
(Figure 3-8d). Hence all the strains- H99, ady2, ato2 and ady2ato2 grow in GM-BCP but 
ady2ato2 is slow to alkalinize it. Alkaline pH altered nutrient acquisition needs of C. 
neoformans growing in YNB supplemented with 0.5% acetate such ady2 and ady2ato2 
but not ato2 were growth-impaired (Figure 3-9). However, growth to wild type levels 
was observed in YNB supplemented with 0.5% acetate at pH 4.5 even though there was a 
general growth decline in acidic compared to neutral pH (Figure 3-9). During growth in 
nutrient rich YPD at varying pH of 4.5, 7 and 8, ADY2 expression was consistently 
uninduced (Figure 3-10). However, its transcript levels were elevated at pH 7 and 8 
during growth in YNB supplemented with 0.5% acetate, but not at the acidic pH 4.5 
which is below Pka of acetate (Figure 3-10). ATO2 remained uninduced during growth in 
nutrient rich YPD at pH 7. However, at pH 4.5 and 8 it is slightly downregulated. 
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Throughout growth in YNB supplemented with acetate at pH 4.5, 7 and 8, ATO2 was not 
induced. (Figure 3-10). 
Overall, C. neoformans growing in nutrient limiting conditions instigate pH 
modulation towards alkaline conditions during which Ady2 was highly upregulated 
relative to glucose rich YPD. 
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Discussion and conclusions 
In a previous study, we identified Ady2 as being the acetate transporter induced 
and required for uptake of deprotonated acetate during nutrient limitation. Moreover, 
Ato2 was required after prolonged exposure of C. neoformans to starvation (Dissertation 
Chapter 2). The requirement of acetate transporters during in vivo conditions that mimic 
the physiological environment encountered by C. neoformans during establishment of an 
initial lung infection led us to predict that acetate transport would play a significant role 
in C. neoformans pathogenicity by mediating metabolic adaptation to the different 
environmental niches afforded by the host.  
In this study we sought to investigate the impact of loss of ADY2 and ATO2 on C. 
neoformans virulence. We expected that this diminished ability to execute metabolic 
adaptation to harsh physiologically-relevant conditions would impact C. neoformans 
capacity to persist in the host, thus resulting in diminished virulence. Therefore, we first 
explored the general morphology of H99, ady2, ato2, and ady2ato2 followed by 
characterization of these strains during conditions that resulted in induction of virulence 
factors and survival in physiological niches both in vitro and in vivo. We found that loss 
of Ady2 and Ato2 led to cell-cell aggregation (Figure 3-1a) resulting in flocculation 
characterized by cell-cell aggregation forming clumps that settle in a pellet in liquid 
culture (Figure 3-1b). This phenotype is typically seen in the yeast S. cerevisiae after 
stopping cell division due to nutrient limitation (Smit et al., 1992).  
A comprehensive look into genes that affect colony morphology implicated the 
SNF1/PKA pathway, a master programmer of metabolic and transcriptional activities of 
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cells in response to nutrient availability (Voordeckers, et al., 2012). Therefore, the 
impairment of ady2ato2 strain in utilizing acetate as a sole carbon source to generate 
acetyl-CoA, a key central metabolic energy source, is in line with this flocculation 
phenotype. This clumping morphology is also typically seen in bacteria and yeast cells 
with increased expression of adhesins or adhesion proteins (Bumgarner et al., 2009; 
Schembri et al., 2004). Evidence of involvement of the SNF1/PKA signaling cascade in 
adaptation of the yeast S. cerevisiae to nutrient limitation (Voordeckers, et al., 2012) and 
in C. neoformans virulence factors (Hu et al., 2008) led us to hypothesize that disrupting 
Ady2 and Ato2 would perturb metabolism adaptation and the interconnections between 
virulence factor expression and pathogenesis. Consistent with this hypothesis, we found 
that loss of Ady2 and Ato2 led to impairment in major C. neoformans virulence 
determinants, specifically, defect in thermotolerance of mammalian body temperature 
(Figure 3-2), and impaired capsule formation (Figure 3-3a) also characterized by 
wrinkled, non-glossy colony morphology (Figure 3-3b).  
C. neoformans Snf1 was found to be essential for virulence, melanin production,
and growth on acetate at 37°C (Hu et al., 2008), which is similar to our observations of 
the thermosensitivity of ady2ato2 and requirement of Ady2 during growth on acetate. We 
therefore infer that the effect of loss of Ady2 and Ato2 in regulating activity of acetate 
uptake may have impacted the intracellular acetyl-CoA pool such that loss of acetate 
transporters led to dysregulation of acetate flux. We hypothesize that this caused 
undesirable fluctuation in the pool of cellular acetyl-CoA, thus impacting cellular 
metabolic expenditures and the virulence-associated capsule acetylation hence deficient 
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attachment in the ady2ato2 strain. We recommend performing an assay to determine 
intracellular levels of acetyl-CoA using commercially available kits. The PicoProbe 
Acetyl CoA Assay kit (Abcam) provides excellent sensitivity at pmol concentrations with 
the advantage of distinguishing and quenching CoA that are not complexed to acetate 
(Zhang et al., 2016). 
Like C. neoformans, the bacterium Escherichia coli has a capsule whose 
polysaccharides provide immune and environmental protection hence classified as a 
virulence determinant. Schembri et al (2004) demonstrated that E. coli capsule shields the 
function of antigen 43 (Ag43), a self-recognizing adhesin that confers flocculation and 
cell-cell aggregation. Therefore, the observed cell-cell aggregation, wrinkled colony 
morphology and flocculation of the ady2ato2 double mutant C. neoformans could be a 
result of impaired capsule attachment that leaves cell surface adhesins exposed. Western 
blots with specific antibodies to detect differentially shed capsule in supernatants of H99, 
ady2, ato2 and ady2ato2 strains during capsule inducing conditions could reveal a role of 
acetate transporters in capsule attachment.  
Additionally, flocculation of ady2ato2 may be attributable to this strain’s 
disrupted homeostasis of intracellular acetyl-CoA reserves as a result of acetate uptake 
defect. This may in turn interfere with acetylation-mediated interconversion of chitin into 
chitosan, a fungal cell wall component that is required for bud separation resulting in 
flocculation and is quantifiable (Baker et al., 2007). In the event of failure in cell 
separation, flocculent cells would not be readily dispersed by mechanical agitation 
techniques such as sonication (Baker et al., 2007). Should such cells be mechanically 
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dispersed, it would be irreversible. Flocculent Cryptococcus strains are typically 
virulence-attenuated (Zaragoza et al., 2006; Wormley et al., 2005; Wang et al., 2012), 
which could partly be due to efficient clearance as a result of their diminished ability to 
evade immune recognition. These results from exposed cell surface antigens that become 
easily discernable by the host innate and humoral immune components upon loss of the 
capsule envelope.  
Similar to observations of the flocculent clump+ strains reported by Zaragoza et 
al., (2006), we observed that unlike the wild type H99 and single mutant strains, ady2 and 
ato2, the flocculent ady2ato2 strain was relatively more susceptible to clearance by 
PMA-activated J774 macrophage-like cell line and human neutrophils. Zaragoza et al., 
(2006) observed that clump+ C. neoformans exhibited higher adherence to macrophage-
like cell lines and were therefore more efficiently phagocytosed. Ady2 and Ato2 
contributed to clearance by these phagocytes. Moreover, ady2ato2 mutant's susceptibility 
to phagocytes anticryptococcal activity (Figure 3-5) was consistent with its capsule 
deficiency because the capsule has been reported to play a significant antiphagocytic role 
of C. neoformans by macrophages (Harrison and Levitz, 2002; Mukherjee and 
Casadevall, 1995), dendritic cells (Vecchiarelli et al., 2003) and neutrophils (Dong and 
Murphy, 1997). Mukherjee and Casadevall (1995) observed that complement-mediated 
phagocytosis of C. neoformans was dependent on the subcellular location of the major 
opsonin, complement component 3 (C3) in the polysaccharide capsule. They reported 
that an increase in capsule size diminished complement-mediated phagocytosis and 
pathogen clearance. These findings suggested a capsule-aided immune evasion 
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mechanism involving disruption of the location of C3 deposition hence inability to 
opsonize C. neoformans for host immune recognition (Zaragoza et al., 2003).  
Impairment of the ady2ato2 strain in melanin formation (Figure 3-4a) is likely 
linked to a relatively slower growth rate of this strain as it starts to melanize when a 
higher cell density is used (Figure 3-4b). Melanin formation results from phenoloxidase-
mediated polymerization of such diphenolic compounds as dopamine (Rhodes et al., 
1982). In the mammalian host, C. neoformans are hypothesized to utilize the diphenolic 
catecholamines in the brain to synthesize melanin hence protecting themselves against 
free radicals and successfully disseminating in the host (Jacobsen and Tinnel, 1993). 
Melanization was found to be protective against reactive oxygen and nitrogen species, 
and therefore conferred resistance to C. neoformans killing by macrophages’ oxidative 
compounds (Wang and Casadevall, 1994).  
The ady2ato2 growth defect in the mammalian temperature, 37oC was consistent 
with our hypothesis that disrupting acetate transport could upset crosstalk between 
effectors of the SNF1/PKA signaling cascade between metabolism adaptation and 
virulence factor elaboration. This hypothesis was also supported by Alspaugh et al., 
(2002) who observed that C. neoformans SNF1 (the yeast ortholog of mammalian PKA) 
and its second messenger, cAMP are integral to the virulence factors; capsule and 
melanin formation and in virulence in a mouse model. Moreover, the fungal plant 
pathogen Neurospora crassa deficient in PKA are temperature sensitive and have an 
abnormal morphology (Bruno et al., 1996). Our findings suggest that Ady2 and Ato2 
could be involved in this signaling pathway through nutrient sensing to relay survival 
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mechanisms that confer persistence in the host, thus enhancing the virulence of C. 
neoformans.  
This temperature sensitivity to mammalian body temperature and capsule defect 
led us to hypothesize that this strain would be have virulence attenuation in the vertebrate 
(mouse) model (Figure 3-6). We hypothesized that the metabolic adaptation role of 
acetate transport could be induced by the dynamic mammalian environmental niches 
which provide a multiplicity of challenges that C. neoformans must either adapt to or 
modulate in order to facilitate persistence in the host. This neutral-alkaline pH is initially 
encountered as C. neoformans cells gain access to the lung tissue followed by a slightly 
acidic pH and nutrient limitation inside activated phagocytes that ingest them. Once in 
blood circulation, fungemia exposes C. neoformans to 5-7.5 mM glucose and a slightly 
alkaline pH of 7.4. Increase in pH compromises membrane proton gradient and 
diminishes uptake of nutrients as observed during growth of C. neoformans.  
We also observed that Ato2 had a role in acetate uptake during prolonged 
starvation. Moreover, this study demonstrated that nutrient rich conditions in YPD caused 
media acidification (Figure 3-7) while nutrient limiting conditions under study led to 
media alkalinisation (Figure 3-8, Figure 3-9). This suggested that nutritional status 
affected pH dependent metabolic signaling. A connection between the pH responsive 
transcription factor, Rim 101 and the cAMP/PKA master regulator of nutritional-
mediated control of cellular and biosynthetic cascades was observed in C. neoformans 
such that Rim101 mutants were defective in growth during alkaline conditions (Kronstad 
et al., 2011). Consistent with our observation that during growth in the glucose-rich YPD, 
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C. neoformans actively acidifies the media, Vylkova et al., (2011) observed that C.
albicans media alkalinization was glucose repressible. 
The ability to modulate pH is essential for optimal function of proteins during 
relevant conditions. Hence this study’s observation of conditional pH adjustment by C. 
neoformans wild type, ady2 and ato2 single mutants but not the ady2ato2 double mutant 
in response to preferred carbon source availability, suggests an involvement of Ady2 and 
Ato2 in active adaptation to dynamic niches of physiological relevance. A deletion of C. 
albicans ATO5, a C. neoformans ADY2 and ATO2 homolog, led to a defect in media 
alkalinization (Vylkova et al., 2011). A high pH generally affects nutrient bioavailability 
to C. neoformans especially during starvation. Changes in pH beyond ideal pKa of 
alternative carbon source affects overall charge, thus diminishing passive diffusion of 
alternative carbon sources across membranes and necessitating energy dependent nutrient 
uptake of charged carbon sources. This is substantiated by our observation that ADY2 was 
both transcriptionally elevated (Figure 3-10) and required for acetate uptake during 
nutrient limitation at high pH but not during growth in nutrient rich YPD.  
Our observation of induction of ADY2 in nutrient limited YNB supplemented with 
0.5 % acetate suggests a role of Ady2 in adaptation to nutrient limiting conditions in a pH 
dependent manner. Overall, ATO2 was uninduced relative to ADY2 (Figure 3-10) 
suggesting it is not involved in transcriptional pH regulation under the conditions tested. 
A slight fold change (2 and below) down-regulation of ATO2 was observed in YPD at pH 
4.5 and pH 8. As two-fold transcript variation is the cutoff below which gene expression 
changes are considered valid based on correlation of RT-qPCR and microarray analyses 
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(Rajeevan et al., 2001a; Rajeevan et al., 2001b), we interpreted this as ATO2 being 
uninduced in both nutrient rich YPD and nutrient limited YNB supplemented with 
acetate. This observation of ATO2 not being induced in neither YPD nor nutrient limited 
YNB supplemented with acetate (Figure 3-10) was expected as Ato2 was consistently 
not required for C. neoformans growth or acetate uptake until cells were subjected to 
prolonged starvation (Dissertation Chapter 2). 
Generally, loss of Ady2 and Ato2 converged phenotypes, which together led to 
high attenuation of virulence, a complex phenotype governed by various adaptive 
properties of C. neoformans. From our observations of the role of acetate transport in 
metabolic adaptation that influences C. neoformans virulence, we hypothesize that 
regulation of acetate metabolism plays a central role in the cAMP/PKA signaling 
cascade, which master-regulates metabolism, facilitates catabolic pathways during energy 
limitation, and inhibits protein, carbohydrate, lipid biosynthesis, cell growth and 
proliferation.  Pathogenic fungi characteristically induce this complex signaling cascade 
resulting in virulence-associated phenotypes during growth in physiological pH. 
Similarly, these adaptive features enable C. neoformans to colonize and persist in the 
host. The key players in these signaling cascades have not been characterized, we 
therefore recommend a comparative genome-scale characterization of the wild type H99 
against the highly virulence attenuated ady2ato2 strain to elucidate the coexpression 
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Figure 3-1. Loss of Ady2 and Ato2 causes flocculation and cell-cell aggregation: A. 
Strains and morphological characterization. a) Cell-cell aggregation was observed by 
fluorescent microscopy of Calcofluor White-stained C. neoformans under x40 
magnification. b) C. neoformans wildtype, ady2, ato2, and ady2ato2 were grown in the 
minimal medium, YNB supplemented with 0.2 % glucose.  Flocculation from cell-cell 
aggregation of C. neoformans cultures grown to mid-log phase was observed by 
simultaneously resuspending the liquid cultures, then allowing them to settle such that the 
most flocculent strain was the first to settle at the bottom of the culture suspension.  
    H99        ady2       ato2     ady2ato2         H99      ady2       ato2       ady2ato2  
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Figure 3-2. Loss of Ady2 and Ato2 impairs ability of C. neoformans to thrive at 
human body temperature.  H99 and mutants lacking ADY2 and ATO2 were grown in 
overnight YPD starter cultures at 30oC to log phase then washed and 10,000 cells were 
spotted onto plates and allowed to roll in columns on YPD plates containing a membrane 
stressor and YNB plate supplemented with 0.2 % glucose. They were incubated at 37oC 
and contrasted to 30oC-grown cells.  
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Figure 3-3. Loss of Ady2 and Ato2 impairs ability of C. neoformans to secrete 
capsule.  a) Overnight YPD cultures of H99, ady2, ato2 and ady2ato2 were grown in 
CO2-independent media at 37oC. A dense cell suspension of the strains was stained in 
India ink at a 1:1 ratio and the capsule was visualized as a halo around encapsulated cells 
when observed by light microscopy. b) Colony morphology of encapsulated H99, ady2, 
and ato2 versus the unencapsulated ady2ato2 was observed on capsule inducing agar 




Figure 3-4. Loss of Ady2 and Ato2 slows melanization of C. neoformans in a cell 
density and growth rate dependent manner.  H99, ady2, ato2, and ady2ato2 strains 
were grown in overnight YPD starter cultures at 30oC to log phase, washed in sterile 
nanopure water and 10,000 cells were spotted onto synthetic media plates supplemented 
with 1 mM dopamine at 4 serial dilutions. The cells were then left to grow in the dark at 
30oC and melanin production was observed by dark pigmentation of the colonies.  
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Figure 3-5. Ady2 and Ato2 contribute to C. neoformans survival during coculture 
with phagocytes. Overnight H99, ady2, ato2 and ady2ato2 cells were grown in YPD and 
resuspended to 1,000 cells/µL in PBS. 80,000 activated J774.16 macrophages (mØ) and 
10,000 opsonized C. neoformans were cocultured at 37oC with gentle shaking for 2 hours 
or 24 hours. Macrophages were lysed and percent surviving CFUs was determined. For 
neutrophils coculture with C. neoformans, blood and serum were obtained from three 
healthy human blood donors (human 1, human 2 and human 3). Human neutrophils were 
concentrated. 80,000 neutrophils and 10,000 C. neoformans cells were cocultured for 2 
hours at 37oC. Percent surviving CFU of C. neoformans were determined. Error bars 
indicate standard deviation from the mean CFU. 
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Figure 3-6. Ady2 and Ato2 are collectively essential for virulence of C. neoformans. 
Using a finely tipped pipette inserted into the mouth, 10,000 C. neoformans were 
inoculated into temporarily anaesthetized C57BL/6 mice (6-7 weeks old) in two 
biological replicates with five mice per H99, ady2, ato2, and ady2ato2 strain. Mortality 
was determined every 24 hours. To determine fungal load in the mice infected with 
ady2ato2 strain murine lungs were harvested, weighed and homogenized. Colony 
forming units (CFU) from lung were determined. This experiment was performed in the 
Levitz lab, Infectious Disease and Immunology, Department of Medicine, University of 
Massachusetts Medical School, Worcester, MA.  
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Figure 3-7. Ady2 and Ato2 are not essential for acidifying YPD. The ability to 
modulate pH in nutrient rich YPD containing the pH indicator, bromocresol purple was 
investigated by inoculating YPD liquid media with H99, ady2, ato2 and ady2ato2 strains 
then incubated at 30oC Colour changes were observed after 20 hours and 72 hours. 
Colour changes relative to pH were calibrated by cell free media adjusted to pH 4.5, pH 7 
and pH 8. Four 10-fold serial dilutions of H99, ady2, ato2 and ady2ato2 started at  OD 
600 of 0.2 were spotted onto YPD agar containing the pH indicator, bromocresol purple 
adjusted to pH 4.5 and 7.0 then incubated at 30oC. 
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Figure 3-8. Ady2 and Ato2 are required to raise pH of nutrient poor media.  
Four 10-fold serial dilutions of H99, ady2, ato2 and ady2ato2 started at OD 600 of 0.2 
were spotted onto GM-BCP agar and liquid cultures supplemented with 0.5 % acetate and 
adjusted to pH 4.5. The set up was incubated at 30oC. a) Cells growing at pH 4.5 
alkalinize GM-BCP after 72 hours as indicated by the colour calibration of the cell-free 
GM-BCP b) C. neoformans growing for 48 hours in GM-BCP media initially adjusted to 




to stain cells as their pH adjusted and colony colour changed. c) H99, and ato2 are the 
first to start alkalinizing GM-BCP while d) ady2 and especially ady2ato2 are slow in 
GM-BCP alkalinization. 
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Figure 3-9. Ady2 is essential during growth on acetate at high pH. Four 10-fold serial 
dilutions of H99, ady2, ato2 and ady2ato2 were spotted onto minimal media, YNB agar 
supplemented with 0.5 % acetate and adjusted to pH 4.5 and 7.0 then incubated at 30oC. 
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Figure 3-10. ADY2 is upregulated in acetate at high pH while ADY2 and ATO2 are 
not induced in YPD at varying pH. After 20 hours of C. neoformans growth in YPD 
and YNB supplemented with 0.5 % acetate (acetate) at their respective pH at 30oC, total 
RNA was isolated and quantitative RT-PCR (RT-qPCR) was performed. Resulting data 
on expression of ADY2 (CNAG_05678) and ATO2 (CNAG_05266) were analyzed 
relative to the reference (UBC6) and control genes (ACT1) as described by Schmittgen 
TD and Livak KJ., (2008). Error bars indicate standard deviation from mean Log2 of gene 
expression fold change values. 
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Our observations of a defect of the ady2ato2 double mutant strain during growth 
at 37oC and capsule formation conditions, led us to speculate that ady2ato2 would not be 
as virulent as H99 because of a possible interactive role of Ady2 and Ato2 that contribute 
to virulence of Cryptococcus neoformans.  This is because ability to grow at mammalian 
body temperature of 37oC and secrete a characteristic polysaccharide capsule are known 
virulence determinants of C. neoformans (Kronstad et al., 2011). The transcript levels of 
genes encoding acetate transporters and acetyl-CoA synthetase (Acs) were elevated 
during mouse lung infection (Hu et al., 2008). Furthermore, expression studies of C. 
neoformans phagocytosed by lung alveolar macrophages, which combat an initial 
infection, reveal a glucose- and amino acid-poor environment (Feldmesser et al., 2000; 
Feldmesser et al., 2001). Therefore, this likely necessitates utilization of such 
nonpreferred carbon sources as lactate and acetate early in establishment of a pulmonary 
infection (Barelle et al., 2006; Lorenz et al., 2004).  Facilitated uptake of acetate could be 
an important survival strategy when carbon-sources are limiting. We postulated that 
acetate transporters shuttled acetate for subsequent activation by Acs to acetyl-CoA thus 
feeding into central carbon metabolism and adaptation to mammalian niches, hence 
facilitating virulence. The wax worm larvae Galleria mellonella has been demonstrated 
to be an invertebrate model for a number of bacterial and fungal pathogens (Mylonakis, 
et al., 2005; Garcia-Solache, et al., 2013; Sabiiti, et al., 2011).  We demonstrated that 
both the ady2ato2 double mutant was avirulent to this model at 37oC while the single 
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ady2 and ato2 mutants had attenuated virulence. As an acs null mutant was attenuated in 
virulence in the mouse model, we included it in our G. mellonella experimental groups to 
provide a mouse model parallel. Here, we further highlight a role in virulence of ady2 
and ato2 as observed in the G. mellonella larvae. 
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Introduction 
The wax moth larva, G. mellonella is an inexpensive model used to evaluate the 
virulence of numerous pathogenic fungi and bacteria (Mylonakis, et al., 2005; Garcia-
Solache, et al., 2013; Sabiiti, et al., 2011). It is a good model because its size and 
morphology allows systemic introduction of known concentrations of inoculum as its 
proleg if slightly depressed opens up an aperture where a needle containing inocula or 
drug is inserted and reseals without significant trauma. This helps immune responses to 
capitalize on the invading infection rather than tissue repair. The ability to live at human 
body temperature, yield results similar to mouse trials, low-maintenance requirements, 
and capacity to respond to known antimicrobial agents that typically clear or ease 
infections in humans all make G. mellonella desirable as a virulence model especially for 
organisms whose pathogeneses involve systemic circulation (Mylonakis, et al., 2005; 
Garcia-Solache, et al., 2013; Sabiiti, et al., 2011).  
As a cryptococcal model, G. mellonella mimics the mammalian system’s immune 
reactions consisting of structural, passive, cellular, and humoral responses to infection 
including phagocytosis, melanization, and encapsulation of large invading pathogens by 
hemocyte layers (London, 2006). Like the mammalian system, G. mellonella survival is 
improved by anticryptococcal treatment using amphotericin B, flucytosine or fluconazole 
given to a larva post infection with C. neoformans (Mylonakis et al., 2005). The cost 
effectiveness, ease of experimental manipulations, similarity to mouse trials, and 
relevance to mammalian immune reactions made G. mellonella an exceptionally 
desirable model organism for our purposes before embarking on the costlier mouse trials 
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graciously performed by the Levitz lab as described in Chapter 3. Necessity of mouse 
trials was highlighted by a few concerns about G. mellonella. Its genome is yet to be 
sequenced, limiting its genetic tractability. Moreover, lack of such visceral organs as 
lungs and brain limits the scope of virulence studies that could be used to decipher 
disseminated C. neoformans at the point of pulmonary colonization and cryptococcal 
meningoencephalitis (Garcia-Solache, et al., 2013). 
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Materials and methods 
In order to determine relative virulence of H99, ady2, ato2 and ady2ato2 C. 
neoformans strains, G. mellonella were infected and handled through a technique adapted 
from Kozubowski and Heitman (2010) and London (2006). The strains were cultured in 
yeast extract peptone dextrose (YPD-DifcoTM) medium at 30oC to mid-log phase. 
Residual cells were collected by centrifugation, then washed thrice in phosphate buffered 
saline (PBS) buffered at pH 7.4 (DifcoTM). The washed cells were then resuspended to a 
concentration of 1 X 105 cells/μL. Prior to injection, the area of inoculation was swabbed 
with 70 % ethanol to prevent interfering systemic cross-infection with surface bacterial 
normal flora of G. mellonella. 10 μL of the cell suspension was injected using a 10 μL 
Hamilton syringe into the left terminal pseudopod region of the larvae. A control group 
received 10 μL of sterile, cell-free PBS.  
Larvae were incubated at 37oC. Determining CFU counts was performed 48 hours 
post infection by first immobilizing and anaesthetizing the larvae at -20oC for 15 minutes. 
Immobilized larvae were then suspended in 1 mL of sterile PBS buffered at pH 7.4 
(containing 1 % of PenStrep stock containing 10,000 μg/mL of Penicillin and 
Streptomycin, ThermoFisherTM). Larvae were then ground using a 607 Mini-BeadBeater 
16 (MIDSCITM) for 30 seconds to obtain a homogenate of full larval contents. 5 x 103 
dilutions of these homogenates were spread onto YPD plates such that should the 
inoculum size have stayed constant in the infected larvae 200 colonies would be obtained. 
Plates were incubated at 30oC and colonies were counted 48 hours later. Melanization 
and mortality resulting from infection was checked by counting dead G. mellonella every 
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24 hours and was plotted on a Kaplan-Meier plot generated by Kaleidagraph version 3.51 
(Synergy Software, Reading, PA). The survival studies were performed in biological 
duplicates with each experimental treatment having ten individuals while the treatments 
used to determine melanization had five individuals per group.  
161	
Results and discussion 
We investigated the relative virulence of C. neoformans H99, ady2, ato2 and 
ady2ato2 strains in the G. mellonella invertebrate model and observed a requirement of 
Ady2 for virulence in this model. Loss of Ady2 led to highly attenuated virulence of ady2 
and ady2ato2 while null mutation of Ato2 and Acs had reduced virulence (Figure 4-1). 
The G. mellonella infected with wild type H99 strain all died by the fourth day that this 
experiment was carried out followed by the ato2-infected group, which died by day 
seven. When the experiment was terminated on day nine, 10 % of the acs-infected, 90 % 
of the ady2-infected, and 90 % of the ady2ato2-infected were still alive. This suggested 
that ady2 and ady2ato2 strains are avirulent while ato2 and acs srains are virulence-
attenuated in the G. mellonella invertebrate model under the conditions tested (Figure 4-
1). This suggests that Ady2 is essential for virulence under the conditions tested while 
Ato2 and Acs contributes to full virulence of C. neoformans. The Acs observation was 
similar to results from mice experiments by Hu et al., (2008). 
After 48 hours of infection, the highest CFU count obtained was 250,000 in an 
ato2-infected larva, which is 4-fold lower than the original inoculum (Figure 4-2). 
Approximately 80 % of the larvae had CFUs below our detectable threshold, suggesting 
that they were still successfully combating C. neoformans infection after 48 hours. We 
recommend a similar study to check CFU after prolonged infection as opposed to 48 
hours and determine the relative roles of Ady2 and Ato2 in proliferation and persistence 
of C. neoformans in the host. The infected G. mellonella also mounted an active immune 
response to the infection as demonstrated by their melanization (Browne and Kavanagh., 
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2013) (Figure 4-3a). Between 20-25 % of the H99, ady2, and ato2-infected larvae had 
melanized while the avirulent ady2ato2 had not (Figure 4-3b).  
The virulence associations of ADY2 and ATO2 to the C. neoformans major 
virulence determinants of capsule formation, and ability to grow at 37oC as described in 
Chapter 3 also complement our observations of a virulence phenotype in G. mellonella. 
Despite the desirable traits of G. mellonella of being inexpensive, experimentally 
manipulable at various temperatures, and significant similarities with mammalian cell 
mediated immune reaction to infection, lack of such visceral organs as lungs and brain 
limits the mouse-Galleria parallels at the point of pulmonary colonization and 
cryptococcal meningoencephalitis (Garcia-Solache, et al., 2013). The mouse infection 
route described in Chapter 3 mimics the natural infection of humans.  Similar to our 
mouse model results described in Chapter 3, we saw consistency in the G. mellonella as 
the ady2ato2 was just avirulent. Although a recent study did not find a consistent 
correlation between Galleria and murine virulence in clinical strains, a correlation did 
exist between Galleria and murine virulence in highly passaged laboratory strains, such 
as the H99 strain used in our studies (Bouklas et al., 2015). 
163	
Figure 4-1. Ady2 is essential for virulence in G. mellonella: Cryptococcus neoformans 
strains H99 ( ), ady2 ( ), ato2 ( ), ady2ato2, ( ), acs ( ) were cultured 
overnight in 2 mL of YPD, then diluted to 1 x 105 cells/mL in PBS buffered at pH 7.4. 10 
μL of the cell suspension and Cryptococcus - free PBS ( ) was injected into the last 
left proleg of 0.27 g-0.33 g white, non-melanized G. mellonella in two biological 
replicates with ten larvae per strain. Mortality was determined by observing larvae every 
24 hours and removing dead or moribund ones.  
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Figure 4-2. After 48 hours of infection, CFU counts of C. neoformans H99, ady2, ato2 
and ady2ato2 in G. mellonella are below the original infection load of Log2=20 
(1x106). G. mellonella were infected with H99, ady2, ato2 and ady2ato2 and incubated at 
37°C.  After 48 hours, their lysates were obtained and spotted onto YPD plates to 




Strain in G. mellonella H99 ady2 ato2 ady2ato2 
Percent melanized G. mellonella 20 20 25 0 
Figure 4-3. After 48 hours of infection, Ady2 and Ato2 contributed to larva 
melanization.  a) The melanized larvae and lysates of G. mellonella infected with H99, 
ady2, and ato2 but not ady2ato2 were observed to have darkened. b) Percent 
melanization of G. mellonella infected with H99, ady2, ato2 and ady2ato2 and incubated 
for 48 hours at 37°C was determined. 
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The Cryptococcus neoformans acetate transporter Ady2 is required and induced 
by acetate during growth in minimal media supplemented with low acetate (≤ 0.5 %) 
(Chapter 2). In order to determine the subcellular localization of Ady2 particularly 
during conditions when Ady2 is required we tagged the N terminal region of Ady2 using 
mCherry under constitutive expression, transformed the construct into ady2 strains 
lacking ADY2 with the dual goal of complementing this strain as well as subcellular 
localization by fluorescent microscopy. We determined stable construct integration and 
protein translation using Western blot and found that mCHERRY had been cleaved in 
subsequent generations, and eventually not present when genomic DNA was analyzed. 
Consistent with this observation, the subsequent generations of this fluorescent 
ady2ADY2 strain gradually lost ability to grow in minimal acetate as sole carbon source, 
a trait characteristic of strains stably expressing wild type ADY2. This suggested that the 
N-terminally tagged mCHERRY::ADY2 strain had not been stably integrated or an
ectopic construct was not heritable in subsequent passaged generations.
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Introduction 
In a bid to determine the subcellular localization of Ady2 during varied 
conditions, we tagged ADY2 at its N terminal with mCHERRY using the plasmid 
pLKB55, graciously provided by Dr. Lukasz Kozubowski (Clemson University). To do 
this, we created a construct that fused mCHERRY upstream of ADY2 under the 
constitutive expression of GPD1 (glycerol-3-phosphate dehydrogenase) promoter as 
published (Kozubowski et al., 2011). We identified the pLKB55 vector with the 
mCHERRY::ADY2 by PCR, Using PDS-1000/HeTM biolistic particle delivery system 
(Bio-RadTM), we transformed the construct into mutant strain intending for the dual 
purpose of complementing this ady2 strain and characterizing nutrient-mediated 
localization of Ady2. We then determined stable integration and translation of 
mCherry::Ady2 using Western blot analysis. 
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Materials and methods 
Construction of mCHERRY::ADY2  
Plasmid DNA was isolated from an overnight pLKB55 cultures grown at 37oC in 
LB (ThermoFisherTM) containing 100 μg/mL Ampicillin (ThermoFisherTM). This plasmid 
also contained the gene that confers Hygromycin resistance (HYG). Genomic DNA was 
also isolated from an overnight wild type, H99 culture grown at 30oC in YPD (DicfoTM). 
The open reading frame (ORF) of ADY2 in addition to 0.3 kb upstream was amplified 
using forward primers that introduced the NheI restriction endonuclease recognition site 
(5’GCTAGC3’) and reverse primer that introduced the Pac1 restriction endonuclease 
recognition site (5’TTAATTAA3’) and alleviated the ADY2 ORF stop codon. These 
restriction endonuclease sites were also in the pLKB55 vector downstream of mCHERRY 
into which ADY2 was cloned. The mCHERRY::ADY2 construct was under the 
constitutive expression of the GPD1 promoter.  
Biolistic Transformation of mCHERRY::ADY2 into Cryptococcus neoformans 
Biolistic transformation was performed according to the methods described by 
Taylor et al., (2015) and the Molecular Mycology Course Handbook (2016). 
Strain preparation: Using primers that anneal to the pLKB55 backbone, ADY2 
insertion downstream of mCHERRY was confirmed. The full length mCHERRY::ADY2 
would be 2.63kb while an empty vector would result in a 0.3kb amplicon. Confirmed 
transformant’s plasmid DNA was isolated and 5 μg was introduced into C. neoformans 
strains lacking ADY2 with the dual goal of complementing this strain and determine the 
subcellular localization of ADY2. To do this, the ady2 strain was grown overnight in YPD 
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at 30oC. An equivalent of OD 600 = 3.0 of cells were pelleted by centrifugation at 3,000 
x g, resuspended in 5 mL of sterile nanopure water and 200 uL of this suspension was 
spread onto transformation plates (YPD supplemented with 1 M sorbitol). These plates 
were allowed to grow at 30oC for 3 hours.  
DNA preparation: DNA macrocarrier membranes (Bio-RadTM) were dipped into 
100 % Ethanol (ThermoFisher) and set aside to dry in a petri-dish containing Drierite® 
(ThermoFisher). 10 uL of vigorously vortexed gold beads, 5 μg of plasmid DNA 
containing the mCHERRY::ADY2 construct, 10 μL of 2.5 M CaCl2, and 2 μL of 1 M 
spermidine-free base, were then added to microfuge tubes and incubated at ambient 
temperature for 10 minutes. 500 μL of 100 % Ethanol was then added, vortexed, and 
pelleted by vortexing at 300 x g for 1 minute. The supernatant was aspirated and 
discarded then this process was repeated once more. 12 μL of 100 % Ethanol were then 
added and the microfuge tube was vortexed for 30 seconds. This gold bead-DNA mixture 
was aspirated and dropped at the center of the dried macrocarrier membrane. The newly 
wet membrane was then placed back into the petri-dish containing Drierite® and allowed 
to dry completely for about 3 minutes. 
Operating the PDS-1000/HeTM biolistic particle delivery system: The vacuum 
pump was switched on then the pressure valve (a silver knob) on the helium tank was 
turned counterclockwise to attain a pressure of 2200 psi visible on the pressure gauge. 
The DNA-containing macrocarrier membrane was then placed in its silver holder, DNA-
side up. A mesh screen (Bio-RadTM; replaced during each biolistic transformation) was 
dipped in 100 % isopropanol (ThermoFisher) and placed into the disc chamber of the 
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white plastic mounting plate. After this, the holder containing the DNA-containing 
macrocarrier membrane was mounted onto the mesh DNA-side down. The cap was 
screwed and this assembled set-up was placed in the highest slot. The biolistic machine 
was then turned on using the red button to the left and the rupture disc holder that hangs 
from the ceiling of the machine was taken out utilizing a torque wrench to first loosen it 
by twisting it to the left. Once completely removed, a 1550 psi rupture disc (Bio-RadTM) 
prewashed in 100 % isopropanol was placed in the holder. The holder was then screwed 
back and tightened using a torque wrench by twisting it to the right; the distance between 
the rupture disc and macrocarrier was about 0.375 inches. The disk chamber was 
thoroughly cleaned using a 70 % Ethanol swab and the petri-dish containing ady2 cells 
(that had been incubated for 3 hours at 30°C) was placed on the petri-dish holder (lid off) 
in the third slot of the biolistic particle delivery system chamber. The chamber door was 
shut and secured then the “vacuum” button was pushed down once until the vacuum 
gauge reached about 29 Hg (within 15 seconds). Quickly, the vacuum button was 
released to resume the down position while switching to pressing the “hold” button. At 
this point, the “fire” button was held until a ‘pop’ sound was made indicating the ruptured 
disc then the “fire” button was immediately released. The “vent” button was pressed to 
vent the chamber to 0 psi. The YPD 1 M sorbitol plate was removed when the chamber 
attained atmospheric pressure and the biolistic machine was turned off and cleaned using 
a 70 % Ethanol swab. The helium gas was turned off by turning the knob clockwise; the 
vacuum pump was then turned off. 
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Selecting mCHERRY::ADY2 transformants: To allow the cells to recover, the 
YPD 1 M sorbitol plates were incubated for 3 hours at 30°C after which all the cells were 
scraped and evenly spread onto a YPD plate containing 100 μg/mL of Hygromycin 
(ThermoFisher) for selection as the pLKB55 vector carrying the mCHERRY::ADY2 
construct contained HYG. These plates were then incubated at 30°C for up to 72 hours 
during which the plates were observed every 24 hours and individual colonies from these 
plates were patched onto fresh YPD plates containing 100 μg/mL of Hygromycin. 
Colony transformants seen to be able to grow in YNB (DifcoTM) agar supplemented with 
0.2 % acetate (unlike the initial ady2 strain before mCHERRY::ADY2 had been 
introduced) were subcultured for protein isolation, western blotting and fluorescent 




Six individual colonies of Cryptococcus neoformans transformed with an 
mCHERRY::ADY2 construct, and the wild type H99 (serves as the negative control), 
cultures were subcultured to grow overnight in YPD. An equivalent of OD 600 = 3 or up 
to 5 x 107 cells were harvested and washed by centrifugation at 300 x g for 1 minute 
using 1 mL ice cold sterile nanopure water before resuspending in 100 uL of sterile 
nanopure water. From these cells total denatured proteins were isolated according to the 
protocol described by Kushnirov (2000). To do this, 100 uL of 0.2 M NaOH was added 
to the cell suspension and the setup was incubated for 10 minutes at ambient temperature 
before centrifuging at 3000 x g. The supernatant was then carefully discarded and the 
resulting pellet was resuspended in 50 μL sodium dodecyl sulfate (SDS) buffer (0.06 M 
Tris-HCl pH 6.8, 4 % ß-mercaptoethanol, 5 % glycerol, 2 % SDS and 0.0025 % 
bromophenol blue). At this stage, samples could either be stored at -20°C or further 
processed by heating immediately at 95oC for 3 minutes followed by a 30-second 
centrifugation at 3000 x g before either storing the samples at -20°C or proceeding to a 
denaturing SDS-PAGE gel prior to performing a western blot. 20 μL of these samples 
were then separated on SDS-PAGE gels at a voltage of 150 for 45 minutes. 
Western blotting 
Denatured proteins in the gel were then transferred to a nitrocellulose membrane 
using a sandwich assembled as follows: first a thick filter paper prewetted in transfer 
buffer (5.8 g Tris base, 2.9 g glycine, 200 mL MeOH, 3.75 mL of 10 % SDS and 795 mL 
of sterile nanopure water), followed by a nitrocellulose membrane also prewetted in 
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transfer buffer, the SDS-PAGE gel containing denatured proteins, and finally another 
thick filter paper prewetted in transfer buffer. This sandwich was arranged on the bottom 
platinum anode of a Trans-Blot SD Semi-Dry Transfer Cell (Bio-RadTM) after which the 
top was secured and its semi-dry chamber layered with of transfer buffer (approximately 
100mL), the blot was ran for 40 minutes at 16 volts. At the end of a successful transfer, 
the nitrocellulose membrane should have gained the proteins originally from the SDS-
PAGE gel, which can be ascertained if a prestained ladder that was initially visible on the 
SDS-PAGE gel is now visible on the nitrocellulose membrane and has faded from the 
SDS-PAGE gel. The nitrocellulose membrane was then washed for 5 minutes in 20 mL 
of TNT (1% of Tris-Cl pH 8.0, 3% of 5 M NaCl, 0.05% of Tween 20 in 1 L of sterile 
nanopure water) wash buffer with gentle shaking.  
To inhibit non-specific binding of antibodies, the nitrocellulose membrane was 
then blocked in TNT wash buffer containing 1 % of nonfat milk for one hour at ambient 
temperature with gentle shaking. After blocking, the nitrocellulose membrane was 
incubated for one hour at ambient temperature with gentle shaking in the mouse-derived 
primary Anti-mCherry antibody (1C51, Abcam) which was freshly diluted 2,000 fold (5 
μL of antibody in 10mL of blocking solution). After one hour had elapsed, the 
nitrocellulose membrane was washed thrice in TNT for 5 minutes per wash with gentle 
shaking. The nitrocellulose membrane was then incubated for another one hour in the 
secondary antibody solution (a 10,000-fold dilution, that is 1uL of the goat anti-mouse 
IgG H&L HRP from Abcam, in 10 mL of the blocking solution). This was followed by 
three additional wash steps in TNT, each 5 minutes with gentle shaking. For visualization 
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of the target protein, we used the ECL western blotting substrate (PierceTM) mixed in 
equal volume, to incubate the nitrocellulose membrane for 5 minutes before drying the 
nitrocellulose membrane, sealing it in clear wrapping paper and blotting it on a film in a 
dark room then developing an X-Ray film (ThermoFisherTM) using an AFP X-Ray Film 
Processor (AFP Manufacturing Co.). 
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Results and discussion 
To determine stable mCHERRY::ADY2 construct integration and subsequent 
protein translation, we used western blot to analyze proteins isolated from six colonies 
subcultured from a C. neoformans ady2 strains that had been transformed (Figure 5-1). 
Despite antibody detection of expressed mCherry, this did not contain the full ~64kDa 
mCherry::Ady2 and was only 24kDa. This suggests that mCHERRY::ADY2 is either not 
heritable, or it is simply not stably integrated but gets cleaved in subsequent generations 
as these six strains also lost ability to grow in minimal concentrations of acetate, 
implying a loss of functional Ady2. The stability of ectopically integrated constructs 
introduced by biolistic transformation varies from 17.5 % - 100 %, while frequency of 
homologous recombination is about 10 % (Lin et al., 2015). It is therefore likely that the 
ectopically integrated pLKB55 containing the mCHERRY::ADY2 was not stable. Arras et 
al., (2015) have described a protocol for stable complementation of C. neoformans genes 
into a “safe haven” locus that stably integrates and is heritable. We are currently 
exploring this site to be used in expressing C-terminally tagged ADY2 also with the dual 
purpose of complementing the ady2 strain, or any other genes of interest driven by their 
endogenous promotors. 
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Figure 5-1: mCHERRY::ADY2 construction. From wild type genomic H99, ADY2 was 
amplified and cloned into pLKB55 and a) 11 transformants were checked by colony PCR 
for amplicon sizes (Lanes 1-11) corresponding to mCHERRY::ADY2 (2.63kb) against a 
molecular ladder lane (M) followed by biolistic transformation of confirmed vectors into 
C. neoformans. The colony on lane 5 had the correct amplicon size. b) Fluorescent C.
neoformans transformants were subcutured and heritability of full length mCherry::Ady2 
confirmed western blot. The lanes as labeled contain: L=prestained Ladder (shows up on 
nitrocellulose membrane but not developed film as it is not recognized by antibodies). 1-
6=individual colonies from transformations with mCherryAdy2 construct in pLKB55. 
0=colony with same properties as 1-6 except that the cell numbers were low before 
protein isolation hence low yield. N=H99 (negative control). 





a) Amplifying 1.6kb of 0.3kb 5' + ADY2 ORF
5’ Primer: GGAACGCTAGCTATGTCTGAAACGAAGCTCCC        
3’ Primer: GGAACTTAATTAATACGATAGATGGGGGCAAGTCGGG 
  b) Confirming 2.63kb ADY2::mCHERRY
5’ primer: GGAACCTGTCGCTTGCGTCATCGTAGTA 
3’ primer: GGAACGGGAGGGTGTACATCCTTTTCC 
Table 5-1: Primers used to generate and confirm mCHERRY::ADY2: Primer set a) 
was used to amplify the ORF (open reading frame) of ADY2 in addition to a preceeding 
0.3kb 5’ region was amplified resulting in a 1.6kb fragment. This was then cloned into 
the Nhe1 and Pac1 restriction endonuclease sites of the pLKB55 vector. Using primer set 
b), 11 transformants were checked by colony PCR for amplicon sizes (Lanes 1-11) 
corresponding to mCHERRY::ADY2 (2.63kb) against a molecular ladder lane. This 
primer set anneals to the backbone of the pLKB55 such that without the ADY2 insert, a 
0.3kb amplicon would be obtained. 
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CHAPTER SIX 
Conclusions and recommendations for further studies 
This dissertation provides novel insight into the roles of acetate transporters in the 
environmental adaptation and pathogenicity of Cryptococcus neoformans, the most 
frequent cause of fungal meningitis. With this new insight, there ensued additional 
testable hypotheses, which provide opportunities for continued investigations. This 
chapter will cover the conclusions drawn from these two studies in relation to ongoing 
experimental manipulations. Based on these conclusions, I will make future 
recommendations for continued investigations.  
The first of these studies demonstrated a complementary role of the acetate 
transporters, Ady2 and Ato2 in environmental adaptation. This is because their 
cumulative loss compromised the pathogen’s ability to buffer surrounding pH to 
alkalinity, attributable to ammonia export. Moreover, plate growth assays identified Ady2 
but not Ato2 as indispensable for C. neoformans’ survival during physiologically relevant 
starvation conditions replicated in minimal media supplemented with low acetate 
concentration. A slight contribution of Ato2 to survival in minimal media supplemented 
with acetate, as well as a reiteration of the essentiality of Ady2 was seen during growth 
on liquid minimal media supplemented with low acetate. However, upon increased 
acetate concentration in the media, these transporters are not essential as is depicted by 
growth at wild type levels. Confirmation of the relative contribution of these acetate 
transporters to acetate transport was further highlighted by a dramatic upregulation of 
ADY2 during growth on acetate, while the less effectual ATO2 was only slightly 
185	
upregulated. These observations further suggest that acetate is a signal that induces 
expression of these genes, hence their expression allows for versatile adaptation to low 
nutrient environments and may crosstalk with the cAMP/PKA cascade.  
As expected, initial uptake rates of radiolabeled acetate following overnight 
growth in nutrient rich YPD identified a requirement for Ady2 but not Ato2 in acetate 
uptake. However, upon an additional passage of cells into nutrient poor YNB 
supplemented with acetate for an additional twenty hours, Ato2 also became required for 
acetate uptake. This finding led to the conclusion that both Ady2 and Ato2 are involved 
in acetate uptake, however Ato2 plays a significant role following prolonged exposure to 
starvation conditions and it acts to supplement Ady2 function in meeting the cell’s energy 
requirements. Ady2 and Ato2 were not essential for acetate export as delineated by wild 
type levels of acetate using the techniques used to measure extruded acetate.  
Assuming that our technique of measuring acetate export had enough resolution 
to distinguish acetate export from any other analogous byproduct(s) that could react with 
assay reagents to give signal, I am led to hypothesize that yet another protein may be 
performing this task. This is highly likely because experimental evidence of 
Saccharomyces cerevisiae Fps1p suggests that this membrane aquaglyceroporin channel 
allows export of dissociated acetate across the membrane. Knockouts of Fps1p 
accumulate acetate slower than wild type cells and are more resistant to acetate toxicity 
(Mollapour et al., 2007). Using the amino acid sequence of S. cerevisiae Fps1p, a 
BLASTp search of C. neoformans failed to identify an ORF of significant sequence 
identity. Moreover, there is yet another uncharacterized member of the acetate transporter 
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Gpr1/Fun34/YaaH, Ato3, whose roles may entail acetate export. Therefore, I propose that 
acetate export efforts be undertaken to characterize Ato3 with reference to acetate export 
and carbon source requirements.  
The colourimetric assay which we used to determine acetate export depended on 
conjugation of acetate assumed to be exported into the culture supernatant with 
hydroxamate and detecting its colourimetric intensity with the aid of spectrophotometry. 
However, I cannot completely rule out the possibility that the apparent lack of distinction 
between wild type and mutant cells’ acetate export could be due to low resolution of the 
hydroxamate assay.  In this case, acetate signal could be indistinguishable from such 
structural analogs as butyrate and propionate, which could react with hydroxamate assay 
reactants. This is especially because the target analyte is an enzymatic byproduct from a 
culture supernatant that could contain these analogs. Although published results of the 
hydroxamate assay are robust, alternative approaches could serve to confirm observations 
in this studies using analytical techniques that target acetate as the specific analyte, or a 
metabolomics approach that surveys patterns of excreted metabolites in the supernatant, 
among them acetate.  
I was able to optimize a gas chromatography flame ionization detection (GC/FID) 
protocol (Table 6-1). Preliminary data obtained from this optimized protocol could be 
used to design experiments to detect a target analyte or plan an exploratory metabolomics 
analysis. The FID’s detection strategy is mass-flow rate dependent thus allowing for 
direct detection of the analyte acetate. This avoids the uncertainties that could arise from 
contaminant-prone derivatization. The physical properties of acetate governed our 
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experimental design. Its volatility and thermostability met the criteria for ideal analytes to 
be used in GC analysis. Moreover, as acetate exists in a polar state, the ideal column was 
polar as well. This polar ZB-FFAP column held on to the polar acetate until its boiling 
point was reached at which acetate eluted off the column and proceeded to detection. The 
GC/FID yielded such robust reproducibility that the standard deviation of the mean 
elution time (3.73 minutes) of standard acetate concentrations was ± 0.03 minutes. This 
accuracy was maintained during sample analysis of the culture supernatant such that the 
acetate elution peak was at a mean of 3.77 ± the standard devioation of 0.002 minutes. 
However, as the free access to the MUAL equipment had a sample number cap, we could 
only run samples in N=1 per strain following 30 and 48 hour-long growth in the minimal 
media, YNB supplemented with 2 % glucose.  
Overall, we observed that after 30 hours of culture, acetate recovered in the 
supernatant of wild type, the individual null mutants of ADY2 and ATO2 was statistically 
comparable. However, the acetate concentration of the double mutant dropped below the 
detection limit of the assay (Table 6-2). On the other hand, after 48 hours of culture, only 
the wild type strain had detectable acetate (Table 6-3). This could point to an 
involvement of Ady2 and Ato2 in acetate export. However, the low sample size limits 
statistical power and calls for replications of the experiments using statistical and 
biological replicates to ascertain the roles of ADY2 and ATO2 in acetate export.  
I further propose a larger scale survey of metabolites in culture supernatant with 
the aim of unearthing the metabolic processes being undertaken by each of the strains 
based on loss of a specific transporter. In such a large-scale screen, it is not feasible to 
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fully anticipate possible analyte thermostability, polarity or volatility. Therefore, liquid 
chromatography/mass spectrometry (LC/MS) as opposed to either GC/FID or GC/MS 
may provide a wider range of differential analyte separation than GC-based methods. 
Several optimization aspects of the separation technicalities are anticipated. To start with, 
investigators could assume that analytes of interest will be more polar than non-polar. 
Therefore, this would call for a polar column and non-polar initial solvent conditions. 
With increasing polarity in the solvent, analytes of interest will be released from the 
column relative to their increasing polarity. The MS component would serve to ionize the 
separated analytes and use a mass/charge ratio to identify and quantify it. Alternatively, 
an MS/MS technique could be applied such that it bypasses the LC separation. In this 
case, the sample (culture supernatant) could directly be injected into an MS/MS analyzer, 
which allows for tandem mass spectrometry in several concurrent mass analyzers either 
in time or in space. Adjustments of ionization intensities could be made to fragment 
polymerized compounds and determine whether they are sugars, amino acids, or 
ammonium, or carboxylic acids. Their relative abundance in each C. neoformans acetate 
transporter mutant strains would give insight into the diverse roles being played by these 
proteins and further illuminate their functions and mechanisms of action. 
Results detailed in this dissertation further led to the conclusion that Ady2 is 
required for cellular membrane uptake of deprotonated acetate when concentrations fall 
below a threshold that diffusion only would suffice to meet the cell’s energy demands 
during starvation. Another conclusion that we arrived at is that the mutant phenotypes we 
observed are a direct consequence of loss of function of acetate transporters as opposed to 
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pleiotropic effects arising due to membrane disruption. This is because membrane 
transport employs membrane bound or membrane associated proteins, whose correct 
integration collectively contributes to intact membrane integrity. Additionally, under the 
conditions tested, Ady2 and Ato2 did not contribute to fluconazole resistance. However, 
because acetate is a precursor for ergosterol synthesis and ergosterol is the target for 
fluconazole, we propose a different approach than was used in this study to further 
investigate a possible relationship between acetate transport and fluconazole 
susceptibility. To do this, I suggest media constitution of acetate and fluconazole in the 
minimal YNB as opposed to adding fluconazole to a glucose-containing rich medium. 
This approach would limit the carbon source availability. Consequently, a reduced ability 
to take up acetate for ergosterol biosynthesis under these starvation conditions could 
result in the ADY2 mutants having vulnerability to fluconazole. As Vanden Bossche et 
al., (1992) found that the fluconazole resistant Candida glabrata isolate (B57149) had a 
higher [14C]-acetate uptake rate, we are currently characterizing the roles of Ady2 and 
Ato2 during conditions that necessitate acetate uptake. 
Since my data supported a requirement for Ady2 and Ato2 in acetate transport 
and eliminated non-specific effects from compromised membrane integrity, I was led to 
initiate an ongoing inquiry into the subcellular localization of these genes during varied 
conditions by tagging ADY2 with mCHERRY. I utilized the plasmid- pLKB55 graciously 
provided by Dr. Lukasz Kozubowski (Kozubowski et al., 2011) to create a construct that 
fused mCHERRY upstream of ADY2 under the constitutive expression of GPD1 
(glycerol-3-phosphate dehydrogenase) promoter. This construct could also be used to 
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complement the ADY2 null mutant strain by restoring phenotypes observed during 
growth on low acetate from loss of ADY2. Fluorescence microscopy indicated an elevated 
signal during the conditions concurrent with ADY2 overexpression. I found that when 
cells were grown	for 48 hours in minimal solid media supplemented with low acetate (0.2 
%) during which ADY2 is essential, localization occurs in punctate structures. However, 
during growth in higher acetate (0.5 %), localization is more diffuse with varied 
concentration of signal around the cell’s periphery and within the cytoplasm (Figure 6-1a 
and Figure 6-1b).  
  Efforts to determine stable construct integration and protein translation using 
Western blot (Chapter 5) have revealed that mCHERRY is cleaved in subsequent 
generations, and eventually not present when genomic DNA was analyzed. Consistent 
with this observation, the subsequent generations of this newly generated strain gradually 
lost ability to grow in minimal acetate as sole carbon source, a trait characteristic of 
strains stably expressing wild type ADY2. This suggested that the N-terminally tagged 
mCHERRY::ADY2 strain was not stably integrated or was not heritable as constructed. In 
the light of these subcellular localization observations, I propose genome-editing 
techniques to confirm these data using a native promoter modified from the “safe haven” 
trans complementation strategy (Arras et al., 2015). Moreover, the regulation of ADY2 
expression under its native promotor could also be investigated with technique. This 
strategy was originally created to complement null mutant C. neoformans strains by 
reintroduction of the wild type allele into a small gene-free region which allows for stable 
integration into this targeted region without disrupting other genes, and distinction of the 
191	
new complement strain from wild type contaminants (Arras et al., 2015). However, I 
propose tagging the C-terminus of ADY2 using a fluorescent reporter  such as mCHERRY 
with the aid of overlap extension PCR then introducing this fusion construct into the safe 
haven vector with the dual intent of complementing the null mutant ady2 strain as well as 
determining the localization of ADY2 under different conditions. 
Alternatively, the CRISPR/Cas9 machinery as recently optimized for C. 
neoformans (Arras et al., 2016; Wang et al., 2016) to reduce off target genoome editing 
and enhance stable integration of the cassete of interest can be used.  To do this, a 
fluorescent reporter can be fused to a ‘dead’ Cas9 whose nuclease activity is deactivated 
by D10A and H840A mutations similar to Chen et al., (2013). The CRISPR/Cas9 
eliminates dependency on antibiotic resistance markers thus allowing multiplexing 
techniques and eliminating constraints faced by traditional genome editing techniques 
that are limited by running out of usable antibiotic resistance markers. Simultaneous 
fluorescent tagging of ADY2 and ATO2 with varied fluorescent reporters may be possible 
by designing short guide (sg) RNA to target the mutant dCas9::fluorescent tag fusion to 
its respective gene similar to Lackner et al., (2015). This multiplexing could further be 
extended to investigate interactions between acetate transport and assimilation or 
dissimilation by simultaneously tagging both a transporter and an acetate producing (such 
as acetate kinase) or utilizing enzyme (such as acetyl-CoA synthetase). The same dCas9, 
if untagged to a reporter could bind to ADY2 or ATO2 promotors to effect gene 
knockdown and titrate effects of their reduced expression. Further insight into acetate 
transporter function could be gleaned through CRISPR/Cas mediated tagging.  
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We suggest that for biochemical characterization of acetate transporters, the 
catalytically inactive dCas9 could also be fused to an affinity purification tag and purified 
prior to catalytic analysis for substrate specificities and structural analyses. The same 
sgRNA used to guide the fluorescently tagged construct described above could be used. 
Originally, the type II CRISPR/Cas system native to Streptococcus pyogenes was 
optimized to induce sequence-specific double strand breaks (DSBs) to knockout target 
genes either mediated by homogous recombination, or to induce missense mutations 
through non-synonymous nucleotide substitution mediated by non-homologous end 
joining DNA repair. With the aid of a Cas9 protein, the CRISPR machinery recognizes 
specific target DNA sequences steered by a short guide (sg)RNA and a protospacer 
adjacent motif (PAM) typically 20 nucleotides long (Sander and Joung, 2014).  
The second of these studies identified Ady2 and Ato2 as having synergistic roles 
in virulence of C. neoformans. This conclusion was arrived at because of the highly 
attenuated virulence observed in ady2ato2 such that infected mice never became 
moribund nor died. This leads us to hypothesize that the ady2ato2 strain may have a 
protective effect by activating the immunity to effectively control disease from causing 
fatality. To study this, we hypothesize an experimental design of three test groups of 
C57BL/6 mice in addition to a positive control infected with wild type and a negative 
control group that would remain uninfected. Of the three test groups, one would be 
infected with 10,000 heat-killed ady2ato2 cells, another group would receive an equal 
inoculum of viable ady2ato2 cells. Moreover, this strain was heavily impaired in the 
major virulence factors-ability to grow at human body temperature, ability to produce 
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melanin - protective against unfavourable environments, and ability to produce capsule - 
a major immune modulator. This requirement of Ady2 and Ato2 for capsule formation 
and a connection to efficient phagocytic anticryptococcal clearance was demonstrated in 
this study. Efficient clearing of the double mutant by human phagoctyes and 
macrophages converged with the acapsular quality of the strain.  
I hypothesize that capsule defects caused the double mutant strain to be more 
recognizable by phagocytes, hence it was easier to clear them during a coculture. Studies 
are ongoing to further characterize the roles of these acetate transporters during osmotic 
stress, different cell wall stresses and titrations of temperature using starvation media 
formulations instead of glucose-containing media that do not elicit significant 
phenotypes. Of particular interest is a study into the possibility of sorbitol to alleviate 
temperature sensitivity (Garcia et al., 2015) of ady2ato2, which we found was not 
differentially susceptible to cell wall and membrane pertubing Congo red and SDS. As 
weakened cell wall could result in temperature sensitivity and reduced viability yet 
ady2ato2 has no obvious membrane or cell wall defect, possible phenotypic remediation 
of its thermosensitivity by sorbitol would suggest membrane or cell wall damage at the 
ultrastructural level and necessitate electron microscopy. 
My general conclusion given the data on acetate transporters and their impact on 
C. neoformans virulence is that acetate transport plays a significant role in its
pathogenecity by allowing adaptation to the different environmental niches afforded by 
the host. To elucidate the mechanisms employed in virulence association to acetate 
transport, we recommend several follow-up experiments. First, I suggest a whole-genome 
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survey of wild type and the double mutant strains through RNA-Seq. Through 
multiplexed gene expression information gleaned from wild type versus double mutant 
strains during infection, phagocyte coculture, growth at 37oC, and capsule inducing 
conditions, we can determine differential expression patterns and tie them to virulence-
associated  mechanisms. Expression information about immune activation of different 
pathways could be gleaned from RNA-Seq. This could provide important information 
regarding the efficiency of immune-mediated pathogen clearance.  
Secondly, an alternative infection to the one used in this study route could be used 
to introduce C. neoformans to C57BL/6 mice. In this study, an inhalation route was used 
to model the natural infection route. With this, the pulmonary environemnt is the initial 
infection site, which poses a difficulty in determining the role of genes under study 
during disseminated cryptococcal meningitis. Alternatively, a tail vein injection would 
ensure fast delivery to the brain and provide further insight into the roles played by 
acetate transporters during neural involvement, the stage that proves fatal in most human 
cases. My third suggestion involves an immunological study using enzyme linked 
immunosorbent assay (ELISA) to study the cytokines elicited by immune cells following 
invasion. Comparative analysis of responses of the avirulent ady2ato2 mutant versus the 
wild type strain could reveal mechanisms that make it easier to abolish virulence of the 
double mutant strain. 
In order to support prolific research on protein families that show promise as drug 
targets, I recommend a forward genetic approach using random mutagenesis to create 
unidentified mutants followed by a screen of these resulting mutants to identify those that 
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are defective in acetate transport. This would help generate a library of candidate genes 
that can be characterized to fully elucidate underlying mechansims responsible for acetate 
metabolism and relevant virulence links. Furthermore, I recommend expression and 
purification of the wild-type Ady2 and Ato2 followed by screening of a panel of 
compounds to identify inhibitors which when bound to these acetate transporters would 
phenocopy deletion of the ADY2 and ATO2 open reading frames. Additionally, the 
development of a manually curated ‘smart’ library could act as a repository for both 
published and highly proofed unpublished data. To do this, we suggest a ranking system 
to weight data guided by a research group’s collective domain-specific knowledge. The 
aim of this would be to structure available data on a protein family into a searchable 
novel database. The eventual goal for this database would be to foster collaborative 
curation of large amounts of published and well-founded but unpublished data being 
continually churned by research groups. Consequently, predictive algorithms could be 
used to ‘mine’ patterns from data on specific proteins to generate hypotheses from 
discovery of models gleaned through automatic knowledge discovery. Not only will this 
allow for confident and efficient hypothesis generation, but it will also provide a platform 
for learning from unpublished negative data, hence elminate redundant experimental 
approaches and guide researchers towards novel approaches. Interactions between protein 
families could also be unearthed from high throughput genomics, proteomics 
metabolomics and other omics data.  
I am manually curating this database “Eukaryotic Pathogens Hypothesis 
INnovation (EPHIN)” (coded by Steven Cogill, Stanford University, Emergency 
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Medicine, Palo Alto, Ca.) as a web application with a very small foot print. We are 
currently running our system on a windows 2012 server and our application is written 
using the fuelphp framework for the latest version of xamp which includes compatibility 
with php 5.6 and php 7. As of now our mysql database is 35 KB and our application is 
15.7 MB. It is growing larger as we add more data to our classification forms. These 
forms were generated using overarching topics from manuscripts that had characterized 
GPR1/FUN34/YaaH family of acetate transporters. The forms provide a general profile 
for a protein, indicating the organism under study, the gene name(s) and sequence, 
protein name(s) and sequence, its functional annotations according to NCBI and Uniprot 
before highlighting possible genome edits used to study it. Specifically, it lets the curator 
select from such genome edits as deletion of complete open reading frames, protein 
segment truncation, site directed mutagenesis of defined non-synonmous amino acid 
substitution, overexpression, random mutagenesis and RNAi mediated gene knockdown. 
This is followed by a ranking the effect that this genome edit had on the organism or 
protein during such experimental conditions as carbon source utilization/substrate 
specificity, drug and inhibitor susceptibility, virulence determinants and colony/cell 
morphology.  
Expression of a wild type allele during this conditions is also documented if the 
data is available. If data is published, links and references of all the publications are 
uploaded into the database. Analyses and information used to generate this database so 
far is illustrated in Figure 6-2. Pulling from all these sources, a snapshot of the weighted 
significance of this dissertation’s study of C. neoformans Ato2 was generated as 
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illustrated in Figure 6-3. Alongside each snapshot generated is information on the 
number of studies used to generate it. The direction that creation of this database is 
forging will facilitate an objective understanding of pathogenicity and promote efficient 
use of resources on highly proofed research hypotheses from mining of large data sets. It 
will be extensible such that different protein families classification schemes can be 
created according to its specific factors. 
The studies detailed in this dissertation have served to fill vital knowledge gaps 
on previoulsy uncharacterized C. neoformans acetate transporters by establishing their 
roles in pathogenesis and metabolic adaptations. These new insights have created new 
study questions that present opportunities for continued study as explored in this chapter. 
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Time (minutes) Temperature ramp Temperature (∘C) Hold time 
0 10 ∘C/minute 80 1 minute 
10 170 1 minute 
Technical conditions 
Splitless liner 
Injection volume - 2.0 μL 
Purge flow – 2 mL/minute 
Carrier gas - H2 at linear velocity of 45cM/s 
Detector - FID 
Polar column (ZB - FFAP):30 m X 0.25 mM X 0.25 μM 
Table 6-1. Optimized conditions used to detect acetate in culture supernatant with the aid 
of gas chromatography/flame ionization detection (GC/FID).
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30 hours 
Strain mM [acetate] Retention time (minutes) 
H99 1.029 3.771 
ady2 1.175 3.767 
ato2 0.972 3.775 
ady2ato2 0 none 
Table 6-2. Concentrations of GC/FID measurements of acetate recovered in the 
supernatant of H99, ady2, ato2 and ady2ato2 strains grown at 30oC in YNB 
supplemented with 0.2 % glucose for 30 hours (N=1).
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48 hours 
Strain mM [acetate] Retention time (minutes) 
H99 2200 3.759 
ady2 0 none 
ato2 0 none 
ady2ato2 0 none 
Table 6-3. Concentrations of GC/FID measurements of acetate recovered in the 
supernatant of H99, ady2, ato2 and ady2ato2 strains grown at 30oC in YNB 
supplemented with 0.2 % glucose for 48 hours (N=1).
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Figure 6-1. Localization of mCHERRY::ADY2 during growth at 30oC for 48 hours in 
YNB supplemented with a) 0.2 % acetate and b) 0.5 % acetate.
a) b) 
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Figure 6-2. Eukaryotic Pathogens Hypothesis INnovation (EPHIN) database 
schematic. Analyses and information used to generate the extensible Eukaryotic 
Pathogens Hypothesis INnovation (EPHIN) database is presented on this schematic 
(Kisirkoi G. and Cogill S., unpublished). The system is running on a windows 
2012 server and its application is written using the FuelPHP framework for the latest 





Cryptococcus neoformans Ato2 snapshot 
Figure 6-3. Data obtained from Cryptococcus neoformans experimental 
manipulations of Ato2 was uploaded onto EPHIN and used to create this snapshot 
(Kisirkoi G. and Cogill S., unpublished). The FuelPHP framework based on which 
EPHIN is created summarizes empirical data from published and unpublished sources 
into a snapshot. 
